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ABSTRACT 
SHARON L. OXENDINE: Exploring a fish model of developmental neurotoxicity using 
the Japanese medaka fish (Oryzias latipes) 
Ethanol exposure induces profound disruptions in developing organisms, but the 
period(s) of maximal susceptibility for these effects are not clearly defined. The overall 
hypothesis of this dissertation was that the timing of developmental ethanol exposure 
would influence manifestations of ethanol toxicity in medaka. Hatching success and 
morphometric measures of medaka growth and development were used to assess the dose-
response for developmental ethanol toxicity. Specifically, medaka embryos were exposed 
to a range of sublethal ethanol concentrations (0.1, 0.5, ot 1.0 % ≡ 17.2, 86, or 172 mM) 
during early, middle or late development in order to address temporal variations in 
sensitivity. Ethanol-induced decreases in total body length were found to be most severe 
with increasing ethanol concentrations that occurred either early or late in embryonic 
development, whereas head width was consistently decreased at all ethanol 
concentrations, regardless of developmental timing. These effects were accompanied by 
dose-related decreases in hatching success which were more pronounced with ethanol 
exposures that occurred early in development. Subsequent analyses of time-dependent 
changes in brain growth and caspase-3/7 activation were used to address the 
neurodevelopmental consequences of ethanol exposure. In these studies, medaka embryos 
were exposed to 1% ethanol during early, middle or late development and evaluated for 
treatment-related changes in brain volume and caspase-3/7 activation on day 9 
postfertilization. Interestingly, the pattern of sensitivity observed for ethanol-induced 
decreases in total brain volume was similar to that seen with ethanol-induced decreases in 
somatic growth; embryos treated either early or late in development were most severely 
affected. Treatment-related decreases in caspase-3/7 activity were independent of 
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developmental timing. In general, these data show that the sensitivity to developmental 
ethanol exposure varies according to both the timing of exposure and the endpoint used to 
assess toxicity.  
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 CHAPTER 1. 
INTRODUCTION 
What is fetal alcohol syndrome? 
Maternal ethanol abuse is the leading known, preventable cause of mental 
retardation in the Western world (Abel and Hannigan 1995; Abel and Sokol 1987; 
Chiriboga 2003), even though studies dating back to the early 1900’s clearly indicate that 
consumption during pregnancy can adversely affect the fetus (Stockard 1910). Although 
Lemoine and coworkers were first to present clinical evidence of ethanol-induced fetal 
malformations (Lemoine et al. 1968), the term “Fetal Alcohol Syndrome” (FAS) was 
originally coined in the U.S. to describe a constellation of physical and cognitive 
abnormalities observed in children of alcoholic mothers (Jones and Smith 1973). 
Manifestations of FAS have since been described in most countries of the world. Affected 
individuals usually present with a spectrum of anomalies including growth deficiency, 
cognitive impairment, and distinctive craniofacial features (reviewed in Coles 1993; 
Meyer and Riley 1986; Smith 1997; Streissguth et al. 1986).  
The association between ethanol consumption and adverse outcome during 
pregnancy is well established (Abel 1980; Henderson 1982; Jones et al. 1976; Streissguth 
et al. 1980). Diagnosis, however, has been hampered by the fact that the FAS phenotype 
exists along a continuum which varies considerably in terms of frequency and severity of 
  
 expression. The complete spectrum of effects (craniofacial malformations, CNS 
dysfunction and pre- or postnatal growth retardation) occurs in approximately 0.3% of all 
live births (Charness et al. 1989), generating an estimated lifetime expenditure of 
approximately $1.4 million per FAS child (Abel and Sokol 1991; Clarren et al. 1990; 
Streissguth et al. 1991). Although facial dysmorphology is perhaps the most striking 
manifestation of developmental ethanol toxicity, impaired growth is the most frequent 
consequence clinically and experimentally (Kennedy 1984). Intellectual impairment, 
which appears to be closely linked to ethanol-induced growth inhibition, has been 
documented in the absence of overt toxicity (Abel 1980; Clarren et al. 1978; Kennedy 
1984). 
What is the mechanism of action? 
Many different mechanisms likely contribute to ethanol-induced fetal damage, 
although none have been established with any certainty. Recent literature reviews confirm 
that no single biological mechanism can account for all of the phenotypic abnormalities 
observed in children prenatally exposed to ethanol (Abel and Hannigan 1995; Guerri 
1998; Maier et al. 1996; Michaelis 1990; Michaelis and Michaelis 1994; Phillips and 
Cragg 1982; Schenker et al. 1990; West et al. 1994). Researchers have traditionally used 
mammalian models and cell-culture experiments to investigate developmental ethanol 
toxicity. These approaches have identified a number of potential mechanisms, including 
mitochondrial damage and subsequent increases in oxidative stress, interference with glia, 
neurotrophic factors and a number of chemical signaling systems involved in neuronal 
communication, changes in the transport and uptake of glucose, impaired cell adhesion 
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 and altered gene expression during development. In addition, decreased protein synthesis, 
impaired nutrient utilization, altered prostaglandin homeostasis, and hypoxia are other 
key considerations in ethanol-related growth restriction. Ethanol can exert its pleiotropic 
effects directly, by acting on the conceptus, and indirectly, by interfering with maternal 
support, making it exceedingly difficult to identify specific cause and effect relationships. 
Cell Death 
There are two generally accepted mechanisms of cell death, necrosis and 
apoptosis. These processes can be distinguished by morphological and biochemical events 
that occur during cell death. Cells undergoing necrosis typically swell and eventually 
rupture, spilling cytoplasmic debris that initiates an inflammatory response which 
destroys adjacent cells. Apoptosis is a form of "cell suicide" that systematically deletes 
individual cells, while leaving adjacent cells intact. During this highly regulated process, 
cell bodies shrink and nuclear DNA becomes condensed and fragmented.  Eventually, 
cells disintegrate into “apoptotic bodies” that are engulfed and destroyed by scavenging 
cells (Bredensen 1996a, b). Many physiological events can activate the apoptotic pathway 
including ischemia, mitochondrial dysfunction, oxidative stress and disruption of calcium 
homeostasis. Developmental ethanol exposure is also known to cause apoptosis. This has 
been demonstrated both in animal models of early ethanol exposure (Cartwright et al. 
1998) and in studies of cultured hypothalamic neurons (De et al. 1994). 
Although diverse molecular signals can initiate cell death, activation of specific 
"death-promoting" effector molecules is considered to be a key regulatory event in the 
apoptotic pathway (Bredensen 1996a, b). Caspase enzymes cleave and destroy important 
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 proteins in the cell, thereby initiating programmed cell death (Cohen 1997), but in some 
instances, cells exposed to these “cell death-inducing factors” do not die. Survival 
determined by the balance between pro-apoptotic and anti-apoptotic cellular constituents. 
Disruption of this balance in favor of proteins encoded by "cell death genes" is thought to 
play a role in ethanol-induced apoptotic cell death. Increased expression of anti-apoptotic 
members of the bcl-2 protein family, however, has been shown to prevent ethanol-
induced cell death during development (Heaton et al. 1999). 
Oxidative Stress 
As previously mentioned, oxidative stress and excessive free radical production 
can initiate cell death via several biochemical cascades, including the release of 
“apoptosis-inducing factors” (Bredensen 1996a, b). Ethanol metabolism and subsequent 
generation of reactive oxygen species is known to reduce antioxidant levels. 
Accumulating evidence suggests that this phenomenon may contribute to ethanol-induced 
cell damage and cell death in the fetus (Guerri 1998; Henderson et al. 1995; Kotch et al. 
1995). In addition, animal models have shown that treatment with antioxidants may 
ameliorate ethanol-induced cell damage (Heaton et al. 2000). 
Ethanol-induced free radical production can also damage cells by interfering with 
mitochondrial function. Mitochondria actively sequester calcium ions, and maintain 
calcium homeostasis, which is vital for survival (Choi 1995). When mitochondria become 
dysfunctional, they undergo a process called mitochondrial permeability transition 
(MPT), wherein large holes open up in the mitochondrial membrane, releasing calcium 
  4
 and cytochrome c into the cytoplasm. This process can cause necrosis or apoptosis 
(Kroemer et al. 1997). 
Neurotransmitter Function 
Ethanol is known to adversely affect the structure and function of developing 
neurons by interfering with various neurotransmitter systems, many of which (e.g., 
acetylcholine, glutamate, serotonin, and gamma-aminobutyric acid) serve to orchestrate 
CNS organization during fetal development. For example, glutamate and NMDA receptor 
interactions appear to be critical for stabilizing synapses that form during brain 
development. Developmental ethanol exposure can reduce the number and function of 
NMDA receptors both during early development and during later developmental stages 
(Costa et al. 2000; Rema and Ebner 1999).  
Cell Cycle Perturbations 
Developmental ethanol exposure may damage the fetal brain by interfering with 
the generation of neuronal progenitor cells. Ethanol can decrease neurogenesis in cellular 
proliferative zones by slowing the cell cycle and limiting the number of newly generated 
cells which are able to migrate to appropriate locations and establish synaptic connections 
with target neurons in the mature brain (Miller and Nowakowski 1991). Ethanol is also 
known to interfere with growth factors that regulate cell division (Resincoff et al. 1993). 
Ethanol has been shown to induce cell death in post-mitotic cells by inhibiting growth 
factors that facilitate cell differentiation (Cui et al. 1997; Zhang et al. 1998a, b) and to 
delay the development of serotonergic networks by interfering with interactions between 
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 developing serotonin neurons and astrocytes that support their growth (Eriksen et al. 
2000; Kim and Druse 1996). Under normal circumstances, radial glia become astrocytes 
when neurons reach their final location. This transition occurs prematurely with 
developmental ethanol exposure (Miller and Robertson 1993), causing neurons to lose 
their radial glial guides, stop migrating and end up in abnormal positions that may 
adversely affect survival. 
Excitotoxicity 
Excitotoxicity is another critical determinant of ethanol-related CNS damage 
(Michaelis 1990; Michaelis and Michaelis 1994). Although calcium influx generated by 
NMDA receptor activation is an important signal for normal neuronal development, 
excessive activation of NMDA glutamate receptors can lead to dangerously high calcium 
accumulation inside the neuron (Choi 1995) and cause cell death by apoptosis or necrosis 
(Choi 1995; Pang and Geddes 1997; Zamzami et al. 1997). 
Glucose Metabolism 
Many harmful effects of prenatal ethanol exposure are thought to be related, either 
directly or indirectly, to ethanol-induced disruption of glucose utilization. Glucose is an 
indispensable energy source which is used in the production of a variety of cellular 
constituents that are necessary for survival, such as lipids, nucleic acids, 
neurotransmitters and steroid hormones. Short-term ethanol exposure has been shown to 
significantly reduce cellular glucose uptake and glucose transporter expression in cultured 
rat neurons (Hu et al. 1995). This effect has also been observed in vivo, where prolonged 
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 developmental ethanol exposure was shown to reduce both glucose uptake and GLUT1 
gene expression in rats (Singh et al. 1992). Since glucose plays a crucial role in most 
physiological systems, ethanol-induced dysregulation of glucose transport is a prime 
candidate for potential mechanisms of ethanol-induced growth inhibition and CNS 
damage. 
Cell Adhesion 
Ethanol has been shown to interfere with normal brain development by reducing 
cell adhesion interactions. Neurons must establish cell-to-cell contact during growth and 
development in order to migrate to their final destination and develop the appropriate 
connections which are necessary for survival. Numerous cell adhesion molecules (CAMs) 
assist in various aspects of this process. In humans, defects in L1 CAMs can lead to 
abnormal brain development, characterized by mental retardation, absence of the corpus 
callosum, and cerebellar malformations. These brain anomalies are similar to those found 
in patients with FAS, suggesting that ethanol exposure during gestation may similarly 
affect L1-mediated cell adhesion and thereby contribute to various aspects of the FAS 
phenotype. This hypothesis is supported by the fact that low doses of ethanol (i.e., less 
than 0.05%) inhibit L1-mediated cell adhesion in cultured brain cells (Ramanathan et al. 
1996). 
Ethanol exposure produces a range of structural and functional abnormalities. 
Observed manifestations of FAS depend upon the dose, duration, and pattern of ethanol 
exposure during development. In addition, susceptibility to the deleterious effects of 
ethanol exposure may vary according to the specific cell type and developmental stage of 
  7
 the organism at the time of exposure. Currently, there is no “global” mode of action for 
ethanol-induced developmental toxicity and it is highly unlikely that a single mechanism 
can account for all of the adverse effects that have been documented in the literature. In 
order to gain a better understanding of this problem, researchers must first determine how 
the initiation and progression of ethanol toxicity changes in relation to blood ethanol 
concentration (BEC) and developmental timing.  
What is the relationship between timing and toxicity?  
Although "critical periods" of heightened sensitivity are best documented for the 
dysmorphic effects of ethanol toxicity, data relating to stage-specific neurochemical 
changes and associated functional deficits are lacking with regard to developmental 
ethanol exposure. For this reason, an assessment of neurotoxic potential as it relates to the 
timing of ethanol exposure is warranted. Very few studies have compared ethanol toxicity 
at distinct periods throughout gestation, though some have looked at individual periods. 
Pre-differentiation phase 
Human studies of ethanol exposures that occur prior to implantation are limited 
due to ethical considerations. Pregnancy often remains largely undetected at this point, 
but spontaneous abortions have been reported following ethanol exposure around the time 
of conception (West et al. 1994). Only a handful of animal studies have examined the 
toxic effects of ethanol exposure during this phase of development and the results 
obtained from these investigations are variable. For example, in a mouse study designed 
to investigate the effects of developmental ethanol exposure during pre-differentiation, 
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 mice appeared to develop normally following ethanol administration on GD 6 (Lochry et 
al. 1982). This is contrasted by findings obtained in a similar study conducted a few years 
later, which demonstrated that ethanol exposures on GD1-6 increased prenatal mortality 
(resorptions) and produced significant decreases in fetal birth weight. The latter study 
also reported craniofacial and limb abnormalities in over 80% of affected offspring, 
suggesting that early ethanol exposure may be teratogenic (or lethal) to the embryo 
(Padmanabhan and Hameed 1988).  
Embryonic Period 
The embryonic period is extremely sensitive and ethanol-induced teratogenicity 
has been studied extensively at this stage of development. In humans, ethanol exposure 
during embryonic development may produce craniofacial malformations (e.g., cleft 
palate, microcephaly) as well as cardiac, muscular and skeletal abnormalities (Clarren and 
Smith 1978). A number of rodent strains have been used to investigate the effects of 
ethanol exposure during this developmental period, but results vary considerably. For 
instance, craniofacial abnormalities (Sulik et al. 1981; Webster et al. 1980), ocular 
defects (Cook et al. 1987; Webster et al. 1983), cardiac dysmorphology (Daft et al. 1986) 
and skeletal anomalies (Blakley and Scott 1984; Ciociola and Gautieri 1988) have all 
been reported following ethanol exposure during early embryonic development (GD 7/8). 
Urogenital (hydronephrosis) (Boggan et al. 1989) and forelimb malformations (Gilliam 
and Irtenkauf 1990) have also been noted with ethanol exposures that occur during 
embryogenesis (GD 9/10).  
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 Fetal Period 
Although there are some inconsistencies in the epidemiological data, human 
studies suggest that ethanol exposures during this phase of development generally do not 
produce gross structural malformations, however, they may inhibit growth and produce 
subtle damage within the developing CNS (e.g., cognitive and neurobehavioral deficits) 
by interfering with synaptogenesis, myelin formation, or other critical aspects of neuronal 
development (West 1987). Ethanol-toxicity has also been demonstrated using whole 
embryo culture models. Effects observed in these studies include ethanol-related 
decreases in body length, DNA/protein content and brain development (Brown et al. 
1979; Priscott 1982). Animal models have been extremely useful for investigating the 
effects of ethanol exposure during this particular stage of development. Investigators have 
demonstrated a strong correlation between ethanol exposure late in gestation and fetal 
growth deficiency using rat (Gavin et al. 1994); mouse (Blakley and Scott 1984); chick 
(Boyd et al. 1984; Pennington 1988) and non-human primate (Sheller et al. 1988) models. 
In one rodent study, ethanol exposure during the latter part of gestation (GD 14-21) or 
throughout gestation (GD 1-22) produced weight deficits in offspring, whereas exposure 
to equivalent BECs during an earlier developmental period (GD 1-13) did not (Abel and 
Dintcheff 1978). This observation supports the findings of (Middaugh and Boggan 1991), 
who used a mouse model to demonstrate that ethanol exposure late in development (GD 
12-17) produced greater ethanol-related growth restriction than exposures that occurred 
during earlier stages of development (GD 5-10).  
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 Which stage of development is most sensitive?  
Human Studies 
Although the FAS phenotype is well characterized clinically, there is still no clear 
consensus regarding which periods of development are most sensitive to ethanol toxicity 
because the available information regarding temporal vulnerability is fairly limited. The 
clinical literature only suggests that there are critical periods during development wherein 
the human fetus experiences heightened sensitivity to ethanol. Unfortunately there are 
still no definitive answers regarding temporal aspects of ethanol toxicity due to the fact 
that few investigators have thoroughly examined this question. A number of human 
studies do imply, however, that intrauterine growth retardation is associated with ethanol 
exposure during the latter part of gestation. Women who stopped drinking before the end 
of the second trimester reportedly had babies that were comparable (in terms of birth 
weight and head circumference) to infants of women who never consumed ethanol during 
pregnancy (Rosett et al. 1983; Smith et al. 1986). These studies are strengthened by 
subsequent reports of decreased growth inhibition in offspring of mothers who 
discontinued drinking before the third trimester relative to offspring of mothers who 
drank throughout pregnancy (Coles 1994; Jacobson et al. 1994). These findings are 
inconsistent however, with an earlier report indicating that a significant relationship 
exists between first trimester ethanol exposure and low birth weight (Day et al. 1989). 
This contention is consistent with results obtained in another study which demonstrated 
that ethanol exposure during early gestation was more damaging to cognitive function 
than later and considerably greater ethanol exposures (Clarren and Smith 1978). The lack 
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 of concordance with regard to periods of heightened sensitivity for developmental ethanol 
exposure most likely reflects deficiencies in experimental design, as most failed to 
conduct a complete time course or dose response that would facilitate comparisons with 
exposures that encompass early, middle or late development while using a common  
endpoint to define toxicity.  
Behavioral manifestations of developmental ethanol exposure have also been 
reported in humans. For example, Aronson and colleagues compared children of alcoholic 
mothers who consumed ethanol throughout gestation with those born to women who 
abstained after the twelfth week of gestation. Severe behavioral and intellectual 
abnormalities were noted in children exposed throughout pregnancy, whereas children 
exposed only through the twelfth week of gestation appeared to develop normally 
(Aronson et al. 1997). The authors suggest that this finding is indicative of increased 
susceptibility to developmental ethanol toxicity during the latter part of gestation. 
Unfortunately, this study is compromised by the fact that women who drink late in 
pregnancy generally tend to drink throughout pregnancy, making it virtually impossible to 
discern the effects of early versus late gestational exposure. In addition, women who 
abstain from ethanol early in pregnancy are more likely to possess other positive 
attributes such as better prenatal care or higher socioeconomic status which may improve 
outcome (Day et al. 1991). Hence, these types of studies, which are often used to 
demonstrate that drinking later in pregnancy is most detrimental to the fetus, are limited 
by confounding factors associated with maternal influence. Therefore, human evidence in 
support of critical periods for enhanced sensitivity to developmental ethanol toxicity is 
insufficient. As such, questions regarding how timing affects developmental ethanol 
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 toxicity need to be revisited using animal models that incorporate the appropriate controls 
and facilitate delivery of precise dosages during clearly defined stages of development.  
Non-Human Primate Studies 
Although many early reports suggest that the CNS is most sensitive to 
developmental ethanol exposures that occur during the human third trimester equivalent, 
recent studies have challenged this notion. For instance, Clarren and co-workers have 
suggested that ethanol exposures which occur during early gestation are more damaging 
to cognitive function than later ethanol exposures. These investigators used a non-human 
primate model to show that consumption of as little as six drinks per week (~1.8 g/kg) 
early in gestation was sufficient to produce deficits as severe as those elicited from 
drinking throughout pregnancy (Clarren et al. 1992). This finding is consistent with 
human studies which have shown a strong correlation between ethanol consumption at 
conception and neurobehavioral impairments (Schneider et al. 2001; Streissguth et al. 
1989). Inconsistencies in the clinical and experimental literature most likely reflect the 
complexity of physiological interactions between timing and toxicity that impact 
numerous cell signaling pathways, producing a diverse spectrum of effects. Nevertheless, 
these reports cast serious doubt on the supposition that the human third trimester 
equivalent is the most sensitive period for developmental ethanol exposure. 
Rodent Studies 
In rodents, the early postnatal period (e.g., human third trimester equivalent) is 
generally considered to be the most vulnerable period for ethanol-induced CNS damage 
  13
 (West et al. 1986). For example, in one study ethanol exposure during gestation produced 
no effect on hippocampal mossy fibers, whereas exposures that occurred during the early 
postnatal period dramatically decreased both hippocampal mossy fiber organization and 
cerebellar neuronal density (Hamre and West 1993; West and Hamre 1985). Further 
support for this notion of differential sensitivity was provided by decreases in Purkinje 
cell numbers following early postnatal ethanol exposure (PD 3/4) (Bauer-Moffett and 
Altman 1977) that were not observed when ethanol exposure occurred later in 
development (PD 10) (Pauli et al. 1995). Another research group used behavior, brain 
weight and the brain:body weight ratio to compare ethanol sensitivity across early, middle 
and late development (Tran et al. 2000). In this study, ethanol exposure produced more 
adverse effects in rats treated late in development. These investigators were careful to 
equate peak blood ethanol concentrations across all exposure periods, suggesting that the 
observed temporal variations in ethanol toxicity reflect differences in developmental 
timing rather than ethanol concentration. Therefore the issue of “critical windows” for 
developmental ethanol toxicity is as yet, unresolved.  
Why Medaka?  
Although rodents have been invaluable for conducting experiments that cannot be 
performed in humans, they share a major experimental weakness with humans. Their 
capacity for placental reproduction introduces uncertainty and limits the number of 
embryos that can be produced by each female. In addition, rodent embryos are 
microscopic early in gestation and require sacrifice of the mother in order to gain access 
to them. Another problem with placental reproduction is that treatment-related mortality 
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 may go undetected because embryos that die during development are rapidly resorbed, 
making them unavailable for assessment. These issues are compounded by the fact that 
costs associated with rigorous toxicity testing in vivo may be prohibitive when using 
rodent models.  
 Approximately 15% of the animals used for toxicological studies are devoted to the 
identification of chemical hazards to human development (Bremer et al. 2005). Use of fish as 
alternative models has grown considerably due to mounting socioeconomic pressures against 
animal testing (Ishikawa 2000a). Due to the fact that steroid hormone structure and function 
are highly conserved between fish and mammals, a variety of fish species are now being used 
as models of endocrine disruption both in field and laboratory settings (Bortone and Davis 
1994; Folmar et al. 1996; Gimeno et al. 1998; Ota et al. 2000). Fish models have been used 
to assess a range of mammalian responses to toxicant exposures, including carcinogenesis 
(Hinton et al. 1985), endocrine disruption (Kashiwada et al. 2002), mutagenesis (Mullins et 
al. 1994), oxidative stress (Kelly et al. 1998) and immunotoxicity (Gogal et al. 1999). 
Although best known for their utility in large scale mutagenesis screens, zebrafish (Danio 
rerio) have been extensively studied since the early 1930s and have remained a focal point in 
developmental biology for several decades (Hisaoka 1958). A detailed review of their 
biology and laboratory use is presented by (Laale 1977). These small tropical fish, 
indigenous to East India and Burma, have been widely used as experimental models for 
studies of vertebrate development and genetics (Parng et al. 2002). This is due at least in 
part, to their economic husbandry requirements, high reproductive capacity and rapid 
generation cycle. In addition, axogenesis and morphogenesis of early brain structures are 
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 well characterized in zebrafish (Chitnis and Kuwada 1990; Kimmel et al. 1995). Detailed 
methods for zebrafish culture in the laboratory are available (Westerfield 2000).  
The Japanese medaka (Oryzias latipes) has a vast research history compared to 
zebrafish and a small genome size (~800-1000 Mb) which decreases redundancy (Naruse 
et al. 2004). This fresh water killifish which is indigenous to Japan, Taiwan and Asia, has 
been studied for over a century and has over 1000 research references dating back to the 
early 1900s, making it one of the most extensively characterized fish models in history. 
Many critical events in development are highly conserved across species. As such, 
medaka embryology and brain structure are remarkably similar to human. (Ishii 1967) 
conducted the first morphological analysis of medaka brain development and 
demonstrated that the major structures of the forebrain are well conserved across phyla. 
Since then, many neuroanatomical and developmental studies of the medaka CNS have 
been conducted (Ishikawa and Hyodo-Taguchi 1994; Koster et al. 1997; Kuwada 1986). 
A complete gross and micro-anatomical description of the medaka brain has been 
published (Ishikawa et al. 1999; Iwamatsu 2004).  
Since zebrafish are a well established model of developmental biology (Fishman 
2001), a general comparison between medaka and zebrafish may serve to illustrate the 
utility of medaka early life stage testing. In zebrafish, more than 500 mutant phenotypes 
have been identified which may prove useful for studying various aspects of early 
development. Medaka are hardy fish, as evidenced by the fact that they can tolerate low 
oxygen tensions and a wide range of pH, temperature and salinity requirements which are 
known to adversely affect embryonic development and survival in zebrafish (Yamamoto 
1975). Some of the advantages shared by these two models include: low space 
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 requirements, a small stature (3-5 cm), which facilitates thorough histological sampling at 
a fraction of the cost generated using rodent bioassays and a transparent outer chorion 
which allows for detailed, non-invasive observation of toxicant effects throughout 
development. In addition, medaka fish have enormous reproductive potential, making it 
possible to generate large sample populations quickly, thereby increasing statistical 
power. Individual females reach sexual maturity within 6-8 weeks (compared to 10-12 
weeks in zebrafish) and lay eggs year round (~25-30 eggs/day/female), generating up to 
ten thousand rapidly developing embryos per year (Hirshfield 1980). Medaka and 
zebrafish develop ex utero and exhibit optical clarity throughout embryogenesis, allowing 
egg fertilization and subsequent developmental processes to be assessed easily with a 
dissecting microscope. When embryos are incubated at 26°C, the length of gestation is 
approximately 9 days in medaka and 3 days in zebrafish. The more protracted duration of 
medaka development facilitates investigations that would otherwise be difficult to execute 
during the relatively brief time period required for completion of embryonic development 
in zebrafish.  
As vertebrates, medaka and zebrafish offer distinct advantages over other models 
that have typically been used for large scale screening, (e.g., Drosophila melanogaster 
and Caenorhabditis elegans), by providing a more comparative model for mechanistic 
studies. Since many of the zebrafish mutant phenotypes identified in genetic screens thus 
far are reminiscent of human disease states, this model may provide useful insights for 
corresponding pathophysiology. A recent review includes several examples of clinically 
relevant zebrafish mutants and also describes molecular and genetic techniques that are 
being used to build the zebrafish genomic infrastructure (Dooley and Zon 2000). Medaka 
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 and zebrafish are particularly well-suited for mechanistic studies of development. Both 
genomes have been completely sequenced, making it possible to integrate toxicant effects 
at cellular, molecular and functional levels when investigating the level of concordance 
between fish and mammalian responses to toxicant exposure.  
While small aquarium fish models represent a convenient alternative for 
developmental toxicity testing, there are a number of important issues to consider, as they 
may influence physiological responses. For instance, healthy test animals are essential for 
obtaining repeatable results and limiting confounding factors that could contribute to 
variability or produce spurious data. For example, environmental stressors, like hypoxia 
or poor water quality can adversely affect viability and thereby impact toxicity. High 
salinity conditions have been shown to enhance the negative effects of certain compounds 
(Dyer et al. 1989), whereas increased water hardness may have a protective effect due to 
decreased diffusion across gill epithelia (Noga 1996). Changes in presystemic metabolism 
(Barron et al. 1988) or specific biotransformation enzymes may also limit bioavailability 
(and toxicity) of certain test compounds (Karr et al. 1985). Our ability to extrapolate 
between fish and other species is further complicated by interspecies variability in 
chemical transport, limitations in the amount of blood (or tissue) available for 
assessments and uncertainty regarding variations in organ and/or metabolic function. In 
addition, fish lack structural elements, such as hair, gonads and mammary glands etc., 
normally found in mammals, which may restrict comparative approaches.  
Despite various technical limitations, use of fish as sentinels of toxicity has grown 
in popularity (Ishikawa 2000a; Yamamoto 1975). The relative ease with which large 
numbers of animals can be cultured in a limited space has facilitated a wide range of 
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 studies including those addressing behaviorial (Bryant and Grant 1995; Howard et al. 
1998; Magnuson 1962), pigment (Koga et al. 1999; Oshima et al. 1998; Sugimoto and 
Oshima 1995), vision (Hisatomi et al. 1998; Nguyen et al. 1999; Nishiwaki et al. 1997; 
Seimiya et al. 1997), and genetic research (Koga et al. 1996; Krause et al. 1997; Nonaka 
et al. 1998; Takeuchi 1966; Tanaka et al. 1995; Yasuoka et al. 1995). 
The basic metabolic machinery in fish, (e.g., Phase I and Phase II metabolism) is 
similar to that of mammals, although current evidence suggests that only a few of the 
medaka cytochrome P450 enzyme systems (e.g., CYP1A, CYP2E1) are induced by 
environmental toxicants (Lipscomb et al. 1998; Williams et al. 1998). Medaka are 
sensitive to a variety of known carcinogens and require only a short time interval for the 
induction of tumorigenesis (Hawkins et al. 1998). In addition, the mechanisms underlying 
carcinogenesis and mutagenesis in medaka are remarkably similar to that of human 
(McElroy et al. 2006) making the medaka model an ideal complement for rodent studies 
of known or suspected carcinogens.  
 Fish and mammalian systems share chemical and species-specific responses to 
xenobiotic exposure and therefore manifest comparable toxicities (Bunton 1996). As such, 
lower vertebrate models have the potential to rapidly advance our understanding of the basic 
physiological processes underlying adverse health effects. The identification of specific 
human disease phenotypes in fish has increased confidence in their feasibility as an 
alternative model and secured their standing as important tools for developmental toxicity 
testing. Zebrafish have historically been used for genetic and molecular studies of 
developmental biology, whereas medaka have primarily been used for toxicity testing of 
various life stages (e.g., embryos, hatchling fry, and juvenile or adult fish) (Hinton et al. 
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 2005). Medaka are, however, now increasingly being used as a model for studies of 
vertebrate genetics and mutagenicity (Ishikawa 2000b; Loosli et al. 2000; Nguyen et al. 
1999; Shima and Shimada 1994). The high fecundity and short generation time which is 
characteristic of medaka make these small fish particularly well-suited for large-scale 
screening applications. In addition, the external development of relatively large eggs with 
large pronuclei has made medaka a good model for transgenic (Chen and Powers 1990; 
Ozato et al. 1986; Takagi et al. 1994; Toyohara et al. 1996) and fertilization studies 
(Yamamoto 1961). Accurate determination of specific sites for embryonic and larval injury 
secondary to xenobiotic exposure is now possible using early life stages of medaka 
development (Hamm et al. 1998). In addition, medaka have routinely been cloned using a 
protocol involving deactivation of sperm that serve to activate, but not fertilize, eggs from a 
single female (Naruse et al. 1985). This procedure facilitates the development of identical 
animals, which is ideal for the control of genetic influences. 
 Japanese researchers have developed a number of inbred medaka strains which can be 
used as tools for genetic research (Hyodo-Taguchi and Egami 1985). Inbred strains have also 
been used in radiation biology and carcinogenesis studies (Hyodo-Taguchi and Egami 1989). 
Because medaka inbred strains provide a more homogenous genetic background, they offer 
advantages over outbred strains for the control of experimental variability in a broad range of 
research applications. While use of out-bred strains may well reflect the range of possible 
responses in a heterogeneous population, use of inbred strains facilitates standardization and 
homogeneity of outcome, which is invaluable for mechanistic studies. Both medaka and 
zebrafish models are optimal for in vivo assessments of developmental toxicity and their 
shortened life span make them an ideal alternative for investigating acute and chronic, sub-
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 lethal effects (Ensenbach and Nagel 1995). The inherent sensitivity to chemical exposures, 
the ease with which large sample numbers can be quickly obtained for study and the ability 
to control experimental and extraneous factors make fish models an excellent choice for 
investigating mechanisms of developmental toxicity.  
Goals of this dissertation  
The overall goal of this research was to determine how dose and timing impact 
toxicity in an isolated, self-sustaining organism which develops ex utero. An investigation 
of the effects of ethanol exposure on early life stages of the Japanese medaka (Oryzias 
latipes) eliminates confounding factors associated with maternal influence, allows for 
accurate dosing and precise timing of exposures, and provides an intact nervous system 
for various structural assessments. Experiments described in this dissertation investigated 
the effects of developmental ethanol exposure in medaka embryos using the following 
hypothesis: The timing of developmental ethanol exposure will influence manifestations 
of ethanol toxicity in medaka embryos, as outlined in the following Aims. 
Aim 1 Investigated manifestations of developmental ethanol toxicity in medaka 
embryos.  
Aim II Identified windows of enhanced sensitivity to developmental ethanol toxicity in 
medaka embryos. 
Aim III Determined the correlation between critical periods for heightened sensitivity to 
developmental ethanol toxicity and apoptotic changes within the medaka brain.
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 CHAPTER 2. 
ADAPTING THE MEDAKA EMBRYO ASSAY TO A HIGH-THROUGHPUT 
APPROACH FOR DEVELOPMENTAL TOXICITY TESTING 
In press, Neurotoxicology, 2006 
Preface 
As I began the experiments designed to study developmental ethanol toxicity, a 
series of technical issues had to be overcome. This chapter (now in press) describes a 96-
well microtiter plate adaptation of the medaka early life stage assay which I developed to 
facilitate a reliable, “semi-high throughput” approach for developmental toxicity testing.  
  
 Abstract 
Chemical exposure during embryonic development may cause persistent effects, 
yet developmental toxicity data exist for very few chemicals. Current testing procedures 
are time consuming and costly, underlining the need for rapid and low cost screening 
strategies. Although in vitro methods are useful for screening, these methods do not 
replicate all the intricacies which are characteristic of embryonic development and should 
ideally be complemented by an in vivo screening strategy. In this study, a modification of 
the medaka embryo assay was devised in order to meet the requirements of high-
throughput, developmental toxicity testing in vivo. The Japanese medaka (Oryzias latipes) 
offers several advantages over traditional mammalian model systems, including economic 
husbandry, high fecundity, and rapid ex utero development. In most studies where fish 
eggs are exposed to a chemical, toxicant exposure takes place in a common vessel, with 
many embryos being exposed to the same solution. This type of design is not amenable to 
high-throughput methodologies, does not allow the investigator to follow the same 
embryo throughout gestation and may confound statistical analysis of the results. A 96-
well microtiter plate method was used to facilitate exposure of individual medaka 
embryos within single wells and this approach was compared with the common vessel 
method using the industrial solvent dimethyl sulfoxide (DMSO) as a test compound. At 
lower DMSO concentrations (0 or 1%), the 96-well microtiter plate assay replicated 
results that were obtained using the common vessel method. There was, however, 
increased lethality and decreased hatching rate in the bottle-reared embryos treated with 
higher DMSO concentrations (5% or 10%). Since embryos reared in the 96-well 
microtiter plates never showed an increase in adverse effects (compared to the bottle-
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 reared embryos) at any DMSO concentration, this suggests that the 96-well microtiter 
plate assay may provide a rapid and efficient alternative for developmental toxicity 
screens that utilize fish embryos. 
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 Introduction 
Embryogenesis is highly sensitive to toxicant exposure, yet many chemicals 
currently registered for commercial use lack comprehensive safety data. Considering the 
number of compounds that need testing, novel methods are required to expedite reliable 
hazard identification and to enhance the predictive power of developmental toxicity 
studies (Bantle et al. 1988; Benoit et al. 1982; Birge et al. 1985; Cameron et al. 1985; 
Dresser et al. 1992; Hawkins et al. 2003; Law 2003; Sabourin and Faulk; Weis and Weis 
1987). Various in vitro assays have been useful for screening putative toxicants, but these 
tests cannot incorporate all of the complexities of mammalian development. It would be 
optimal to augment in vitro testing with in vivo assays to provide a more complete 
assessment of neurotoxic potential following developmental exposure to a given 
chemical.  
Japanese medaka fish (Oryzias latipes) offer several advantages for developmental 
toxicity testing, including economic husbandry requirements, high fecundity, and rapid ex 
utero development. Further, the transparent outer chorion facilitates non-invasive 
observations of the embryo throughout development (Braunbeck et al. 2004; Hawkins et 
al. 2003; Wittbrodt et al. 2002). In addition, medaka embryos are known to be sensitive 
to toxicant exposure during development (e.g., Dial 1978; González-Doncel et al. 2003; 
Smithberg; Solomon and Faustman 1987; Villalobos et al. 2000). These attributes make 
medaka an attractive candidate for high-throughput screening. 
In this study, I explored the utility of medaka embryos as a candidate for 
developmental toxicity screens. In order to facilitate the use of robotics in these types of 
screens, a multi-well plate format was adopted for toxicity testing. This method is 
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 preferable to the “common vessel” method which is typically used for embryo toxicity 
assays. Specialized 96-well microtiter plates (described below), were used to compare the 
conventional method of exposing several embryos in a single rearing environment (e.g., 
borosilicate bottles) to the modified, 96-well microtiter plate assay. To accomplish this 
task, medaka embryos were exposed to various nominal concentrations of dimethyl 
sulfoxide (DMSO) (Jacob and Herschler 1986), a commercial solvent commonly used as 
a vehicle in toxicity studies. All embryos were assessed daily for lethality, hatching rate 
and day of hatch. Comparison of the 96-well MultiscreenJ microtiter plate method with 
the “common vessel” method showed that, in general, both treatment scenarios produced 
similar results, suggesting that the 96-well microtiter plate strategy is a suitable 
alternative to the borosilicate bottle method commonly used in fish embryo toxicity 
testing. Moreover, the 96-well microtiter plate method adds individual, serial, evaluative 
and statistical strengths that cannot be obtained with conventional approaches.  
Materials and Methods  
Chemicals  
Embryo rearing medium (ERM, 17.1mM NaCl, 272µM CaCl2 ● 2H2O, 402µM 
KCl, 661µM MgSO4 ● 7H2O; pH 6.3) was used as the medium for all exposures. 
Dimethyl sulfoxide (DMSO, 99.9% purity) was purchased from Mallinckrodt AR© ACS 
(Phillipsburg, N.J.).  
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 Test animal  
The Japanese medaka is a small (3–4 cm) egg laying freshwater fish native to 
Japan, Korea, and eastern China. Embryos used in this study were collected from an 
orange-red line maintained under standard re-circulating aquaculture conditions. All 
procedures were approved by the Duke Institutional Animal Care and Use Committee 
(IACUC) and the U.S. EPA National Health and Environmental Effects Laboratory 
IACUC. 
Embryo collection 
Egg collection and broodstock maintenance followed the experimental procedures 
described by (Marty et al. 1991). Medaka broodstock of the orange-red variety were fed a 
commercial ration (Otohime Beta, Nisshin Feed Co. Ltd., Tokyo) ad libitum and 
supplemented with brine shrimp nauplii for five days each week under a 16:8 hr 
light/dark cycle at 25 ∀ 1° C. Brine shrimp nauplii were reared at 25 ∀ 1° C using a 
secondary container of Instant Ocean (Marineland, Moorpark, CA) under continuous 
aeration. For supplemental feedings, hatched brine shrimp nauplii were taken from this 
secondary container and 1 ml aliquots were fed to the medaka broodstock. Fertilized eggs 
from at least 50 females were siphoned from aquaria within 6 hours of fertilization and 
separated by gently rolling egg clusters by hand to disrupt attaching filaments. Eggs were 
pooled and washed briefly in 20 ppm Instant Ocean (Marineland, Moorpark, CA) to 
inhibit fungal growth. Fertilized eggs were then placed in ERM and staged according to 
Iwamatsu (1994). Embryos of the early high blastula stage (stage 10) were selected for 
study. Embryonic development was examined non-invasively through the transparent 
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 chorion (i.e., egg shell membrane) using a Nikon 1500 stereo dissecting microscope 
(Nikon, Melville, NY). 
Experimental Design  
The experimental design for these studies is shown in Figure 2-1. Two treatment 
methods (i.e., 20 ml borosilicate bottles or 96-well microtiter plates) were used to 
evaluate DMSO toxicity in the medaka embryo assay. To prevent sample bias, embryos 
from collected clutches were pooled, then individual stage 10 embryos were randomly 
assigned to either 20 ml borosilicate bottles or individual wells of microtiter plates. 
Therefore, for each experiment, all embryos in the bottles or the microtiter plates were 
taken from the same mating pairs. Both exposure methods used a total of 10 embryos per 
dose. A stock solution of 10% DMSO in ERM (v/v) was serially diluted using ERM to 
prepare 1% and 5% stock solutions for developmental exposures. Sufficient quantities of 
each DMSO stock solution were prepared to ensure that all exposures used the same 
original stock solutions throughout treatment. Control embryos (exposed to ERM only) 
were included as a reference of normal embryonic development (Solomon and Faustman 
1987). After the 7-day treatment period, embryos were maintained in ERM until hatching. 
Treated and control embryos were assessed daily for mortality and hatching delays. This 
study was done in three cohorts, each started on a different day, with a total n=20 
embryos per DMSO group in each cohort. The data presented here are from all three 
cohorts combined.  
  29
  
    
    
10% DMSO 5% DMSO 
1% DMSO control 
Days 0-7 
10% DMSO 5% DMSO 
1% DMSO control 
    
    
Days 8-15
Compare 
survival 
and time 
to hatch 
 
Figure 2-1 – Experimental Design Overview. Beginning on Day 0, four DMSO solutions 
(10%, 5%, 1%, and 0%) - were administered to medaka embryos. For the 20ml 
borosilicate vial exposures, 2 groups of 5 embryos were exposed to each DMSO 
concentration. In the 96-well microtiter plates, 10 embryos were exposed for each 
DMSO concentration, all on the same plate. Solutions were changed daily from 
Day 0 until Day 7. Beginning on Day 8 and continuing until Day 15, embryos 
were stored in ERM and monitored for hatching rate and lethality.  
Borosilicate bottles:  Viable embryos from pooled clutches were randomly 
distributed into 20 ml screw-capped, borosilicate bottles (catalog 6-74516-20-CS, 
Krackeler Scientific, Albany, NY). Each bottle contained 5 embryos in 2 ml of solution 
and 18 ml of headspace, an approach adapted from (Villalobos et al. 1996). DMSO 
exposures (0, 1%, 5% or 10%) were conducted at 25 ∀ 1° C under a 16:8 hr light:dark 
cycle, and all solutions were renewed daily by aspirating the old solution with a glass 
Pasteur pipette and adding 2 ml of the original stock solution.  
96-well microtiter plates: Multiscreen™ (40 micron nylon mesh) microtiter plates 
(catalog #MANMN4050, Millipore Corp., Bedford, MA) were used for the medaka 
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 embryo assay. As shown in Figure 2-2, these plates consist of three separate components: 
a buffer tray, a sample tray, and a lid. Individual wells within the buffer tray effectively 
compartmentalize each embryo within its own microenvironment. The sample tray has 
nylon mesh at the bottom of each well. This feature permits rapid solution replacement by 
transferring the sample tray to a new buffer tray. Each sample tray may contain up to 60 
embryos, with one embryo per well.  
Cover
Sample Tray
Buffer Tray
 
Figure 2-2 – Diagram of 96-well Microtiter Plate. A diagrammatic representation 
showing the lid, sample tray, and buffer tray of the 96-well microtiter plate used 
for DMSO exposures. Embryos were maintained in the same sample tray 
throughout the experiment and solutions were changed by placing the sample tray 
into freshly prepared buffer trays. 
In these studies, embryos were placed in a sample tray and assigned to either 
experimental (DMSO solutions) or control (ERM) groups. All embryos were pooled from 
the same mating pairs on the same day and randomly distributed into the sample tray. In a 
second buffer tray, 300Φl of ERM or DMSO test solutions were pipetted into each well. 
In addition, 300Φl of ERM was loaded into the remaining wells located around the outer 
perimeter of the buffer plate to mimimize evaporation effects. Each 96-well microtiter 
plate was then sealed with an impermeable adhesive (Microseal®, MJ Research Inc. 
Waltham, MA), covered with the supplied lid, and wrapped in Parafilm® to minimize 
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 evaporation. Medaka embryos were incubated at 25 ∀ 1° C under a 16:8 hr light:dark 
cycle until hatching and all solutions were renewed daily. For daily solution changes, the 
sample tray housing embryos was removed, briefly blotted with a paper towel and then 
lowered into a second buffer tray containing new aliquots of DMSO or ERM stock 
solutions. 
Endpoints 
Viability was determined through visual inspection of the medaka embryos using a 
Nikon 1500 stereo dissecting microscope (Nikon, Melville, NY). Death was defined as 
either the lack of a visible heartbeat or an egg which had become opaque. Hatching rate 
was defined as complete hatching: embryos with heartbeats that were partially hatched 
and unable to exit the chorion fully were scored as ‘not hatched.’ To determine the day of 
hatch, embryos were checked once daily, and if fully hatched, that date was recorded as 
the day of hatch (the day of fertilization was considered day 0). 
Statistical Analyses  
The two, non-parametric dependent variables (lethality and hatching rate) were analyzed 
using an unpaired, two group (borosilicate bottle vs. 96-well microtiter plate) Mann-Whitney 
test (StatViewJ). The parametric data (i.e., length of time the embryo remained in the egg), 
were analyzed using a global ANOVA (StatviewJ) using day of hatch as the dependent 
variable, and dose and Plate or Bottle as the independent variables. Any subsequent 
interactions at the p≤ 0.05 level were followed by step-down ANOVAs. When necessary, a 
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 Fisher’s PLSD post hoc test was conducted to determine differences between DMSO dosage 
groups.  
Results 
The bottle-reared and 96-well microtiter plate-reared embryos showed no 
observable differences from one another with regard to lethality, hatching rate, or day of 
hatch when treated with no DMSO or 1% DMSO (Table 2-1; Fig. 2-3). The borosilicate 
bottles and the 96-well microtiter plates both demonstrated over 93% survivability and 
hatching rate in the controls and the 1% DMSO treatment groups (Table 2-1). The length 
of gestation (i.e., hatching day) was also similar between the borosilicate bottle or 96-
well microtiter plate-reared embryos: bottle = 8.7 ± 0.4 days and 96-well microtiter plate 
= 9.3 ± 0.2 days for the controls, and bottle = 9.3 ± 0.3 days and 96-well microtiter plate 
= 9.1 ± 0.3 for the 1% DMSO treatment groups (all data are presented as mean ± standard 
error of the mean) (Fig. 2-3). Both assays produced comparable results, indicating that 
rearing embryos in the 96-well microtiter plates did not enhance the negative 
consequences of DMSO toxicity when compared to the bottle-rearing method. 
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 Table 2-1: Comparison of survival and hatching rate in bottle- or 96-well microtiter 
plate-reared medaka embryos exposed to different concentrations of DMSO. 
Survival (%) Hatching Rate (%) Concentration 
of DMSO (%) Bottle 96-Well 
Microtiter Plate 
Bottle 96-Well 
Microtiter Plate 
0 96.7 (30)* 98.3 (53) 100.0 (29) 98.3 (52) 
1 93.3 (29) 96.7 (29) 100.0 (27) 100.0 (26) 
5 96.7 (29) 86.7 (30) 53.3 (29) 91.7a (26) 
10 0 (30) 63.3a (30) NA 33.3a  (19) 
 
The hatching rate is calculated only for the animals that survived, e.g., at 10% DMSO, only 
33.3% of the 63.3% of 96-well microtiter plate reared embryos hatched. Therefore only 21% 
(0.333 x 0.633) of the original number of embryos reared in the 96-well microtiter plates 
exposed to 10% DMSO hatched. These are non-parametric data presented as means. 
Comparisons were made using a Mann-Whitney test. *The number in parentheses is the 
number of embryos observed to calculate the percent survival or percent hatching. Indicates 
significant difference between the 96-well microtiter plate- and bottle-reared embryos
a
. 
 
At higher DMSO concentrations (5% or 10%), differences emerged between the 
two exposure methods. Lethality was not different between the borosilicate bottle- and 
the 96-well microtiter plate-reared embryos at 5% DMSO, but at 10% DMSO all the 
embryos reared in the bottles died, whereas only 37% of the embryos reared in the 96-
well microtiter plates died (Table 2-1). Comparison of hatching rate with 10% DMSO is 
not possible because 100% lethality at that dose was observed in the bottle-reared 
embryos. At 5% DMSO, however, only 53% of the embryos reared in the borosilicate 
bottles hatched, whereas there was a much higher hatching rate in the 96-well microtiter 
plate reared embryos (92%, see Table 2-1). Comparing length of gestation between the 
two rearing methods revealed similar patterns: embryos reared in 1% DMSO did not 
demonstrate delayed hatching, whereas embryos reared in 5% DMSO were delayed (Fig. 
2-3). Although both the bottle-reared and 96-well microtiter plate-reared embryos showed 
  34
 delayed hatching at 5% DMSO, this effect was exaggerated in embryos reared in the 
bottles when compared to the 96-well microtiter plate-reared embryos (Fig. 2-3).  
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Figure 2-3 - Effects of Exposure Method on Length of Gestation. Comparison of the 
length of gestation in medaka embryos reared in bottle or 96-well microtiter plates 
and exposed to different concentrations of DMSO. Data are presented as mean ± 
standard error of the means. Data were analyzed using a global ANOVA 
(Statview™) using day of hatch as the dependent variable, and DMSO Dose and 
Plate or Bottle as the independent variables. This global ANOVA indicated an 
interaction between DMSO Dose and Plate or Bottle (p≤.001) with significant 
effects of DMSO Dose or Plate or Bottle alone. Step down ANOVAs indicated that 
(a) 5% DMSO delayed hatching in both the bottle-reared and 96-well microtiter 
plate-reared embryos and that (b) at 5% DMSO, the bottle-reared embryos took 
longer to hatch than the 96-well microtiter plate reared embryos (p≤ .001). * 
Indicates difference between that group and the control and 1% DMSO groups 
reared in the same manner. # Indicates that the bottle-reared embryo gestation 
length is different from the 96-well microtiter plate-reared embryo gestation 
length. 
Discussion 
Early life stage toxicity tests in fish are typically carried out under group rearing 
conditions. The practice of exposing multiple embryos to the same solution in the same 
chamber diminishes statistical power. This approach also obviates serial analysis of 
individual embryos throughout the exposure. Furthermore, as is discussed later, this 
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 procedure may introduce undefined inter-embryonic factors that possibly influence 
toxicity. Herein I describe a rapid technique for developmental toxicity testing that 
circumvents these issues by exposing individual embryos under isolated rearing 
conditions using 96-well microtiter plates. This adaptation enables large sample 
populations to be tested quickly, independently, and with enhanced strength of analysis. 
The specialized 96-well microtiter plate format allows cultured embryos to remain in their 
individual test wells throughout the experimental procedure. In contrast, rearing multiple 
embryos per bottle or Petri dish makes it impossible to follow specific embryos with any 
certainty during gestation. Moreover, when using pipettes to change the incubation fluid 
it is easy to lose embryos, or at the very least, to stress embryos when they are 
inadvertently taken up into the pipette tip with the exposure solution. These 
considerations are alleviated via use of the two-tiered, 96-well MultiscreenJ microtiter 
plates. 
As a test case, comparative studies using DMSO exposure of medaka embryos 
were conducted to assess the similarity between these two treatment paradigms. Our 
findings indicate that at lower DMSO concentrations, toxicity assessments conducted in 
borosilicate bottles were comparable to those conducted in 96-well microtiter plates, 
suggesting that 96-well microtiter plates represent a comparable alternative. It is 
interesting to note, however, that at the higher DMSO concentrations, overt toxicity (i.e., 
death and decreased hatching rate) was accentuated in embryos that were reared in 
borosilicate bottles (Table 1). This observed increase in toxicity at higher DMSO 
concentrations may reflect undefined interactions between embryos reared in a common 
environment, possibly through the release of factors which may negatively impact 
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 survival. In this scenario, if one embryo in a bottle dies, it may be more likely that other 
embryos in the same bottle may become predisposed to death. In fact, there is some 
evidence for a “group-rearing effect” on fish development. Fish embryos raised in a 
clutch showed a different neuroendocrine phenotype than embryos raised individually 
(Nechaev et al. 2000). Interestingly, individual fish embryos will attain a “group-reared” 
phenotype when incubated in water used to rear a clutch of embryos. These results 
suggest that a factor released into the water surrounding a clutch may influence 
embryonic development. An alternative explanation for the observed differences in 
toxicity could be an interaction between DMSO and the containment matrix of the two 
exposure mediums. For instance, the DMSO may be binding to the nylon mesh or 
polystyrene of the microtiter plate, thereby decreasing the effective concentration seen by 
the embryo. In that case, however, the DMSO concentration at which death was first 
observed would be lower in the bottle-reared embryos, which was not observed. At 5% 
DMSO, both the bottle-reared and 96-well microtiter plate-reared embryos showed no 
lethality, with death observed only at 10% DMSO. Future studies will include a 
determination of the actual concentration of test agent in solutions before and after 
incubation in 96-well microtiter plates. Another difference between the two exposure 
methods was available head space. In our experimental conditions, the bottles have a head 
space ratio of 9:1 (18 ml to 2 ml solution), whereas the 96-well microtiter plates have a 
ratio of only 0.33:1.00 (0.1 ml to 0.3 ml solution). Because Marty and coworkers (Marty 
et al. 1990) determined oxygen requirements in rearing solution of borosilicate vials and 
adjusted head space ratio accordingly, it is possible that a decrease in head space may 
affect oxygenation of developing tissues. Less head space in the 96-well microtiter plates, 
  37
 however, did not affect the development in any of the control embryos and did not 
increase the toxicity at any of the DMSO concentrations used in this study. It must be 
noted, however, that the solutions were changed daily with aerated ERM or aerated ERM 
plus DMSO. Thus, the lack of head space could be detrimental to embryos reared in the 
96-well microtiter plates if solutions are not renewed daily.  
Other investigators have assessed the effects of DMSO on embryonic development 
because DMSO is often used as a cryoprotectant for eggs and embryos of many different 
species (Iida 1992; Johnson and Pickering 1987; Mochida et al. 2000; Shaw et al. 1991). 
When used as a cryoprotectant, however, the DMSO concentrations tend to be much 
higher than those tested here. Previous studies in frog embryos (Xenopus) (Dresser et al. 
1992) or medaka embryos (Routray et al. 2002) exposed to DMSO during development 
showed a higher sensitivity to DMSO-induced lethality than was observed in the present 
study. For example, the LC50 for DMSO in frog embryos was 1.92% (Dresser et al. 1992), 
whereas 0.6 M (approximately 4.25%) DMSO was lethal to 40%-50% of the medaka 
embryos after a brief 20 minute exposure at either the 8-cell or “eyed” stages of 
embryonic development (Routray et al. 2002). In contrast, our data showed no lethality at 
5% DMSO when exposure occurred from approximately 10 hours post fertilization 
through 7 days post fertilization. Routray and coworkers (2002), however, did not see a 
dose response relationship with regard to DMSO-induced lethality in medaka embryos; 
even though the DMSO concentration was increased 4-fold, lethality only increased from 
40% to 50%. This result may be because, curiously, the internal concentration of DMSO 
also did not show a marked dose-related increase. For comparison with the present data, it 
would have been much more informative if lower DMSO concentrations had been used to 
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 define the non-lethal portions of the DMSO dose response curve. In a related paper 
studying the effects of 0.04% DMSO on zebrafish embryos, this concentration of DMSO 
did not induce lethality, delayed hatching or decreased hatching rate (Hallare et al. 2004) 
The data presented in this report clearly demonstrate that microtiter plate assays 
are a viable option for medaka embryo toxicity tests. This convenient method provides 
the necessary framework for creating an automated, high throughput screening system 
that will facilitate the use of robotics to investigate toxicant effects on embryonic 
development. 
 
  39
 CHAPTER 3. 
USE OF A FISH EMBRYO ASSAY TO DEFINE VULNERABLE WINDOW OF 
ETHANOL DEVELOPMENTAL TOXICITY 
This Chapter and portions of Chapter 4 are currently under peer review in Aquatic 
Toxicology, 2006. 
Preface 
This chapter addresses the first two Aims of my dissertation and investigates 
temporal changes in ethanol sensitivity during specific periods of medaka development. 
In order to investigate potential “windows” of heightened sensitivity, embryos were 
exposed to a range of ethanol concentrations during early, middle or late development and 
assessed for treatment-related effects on various measures of overt toxicity. Ethanol-
induced hatching delays and growth inhibition were used to compare embryonic 
sensitivity to ethanol toxicity across each exposure window. In general, these results 
suggest that medaka embryos are sensitive to ethanol toxicity at all stages of 
development, but demonstrate a variable pattern of effects depending upon the window of 
exposure.  
  
 Abstract 
Ethanol is a well-known developmental toxicant that produces a range of abnormal 
phenotypes in mammalian systems including craniofacial abnormalities, cognitive deficits 
and growth retardation. Although the toxic potential of developmental ethanol exposure is 
well characterized clinically, the effect of timing on toxicity remains unknown. Fish 
models such as the Japanese medaka, Oryzias latipes, provide a convenient system for 
investigating the effects of developmental ethanol exposure in vivo. In this study, medaka 
embryo toxicity tests were used to assess temporal variations in developmental ethanol 
toxicity. Fertilized eggs were collected and incubated during early, middle or late 
gestation (e.g., 0-3, 3-6 or 6-9 days post fertilization) with various sub-lethal 
concentrations of ethanol (0.1%, 0.5%, or 1.0%; ie., 17.2, 86, or 172 mM). Time to hatch, 
head width, and total body length were used to assess toxicity. Hatching delays were 
noted only at the highest concentration of ethanol, whereas head width was affected at all 
ethanol levels, regardless of the window of exposure. Ethanol-induced decreases in total 
body length, however, appeared to be most pronounced when exposure occurred either 
during the first or last developmental window. Uptake of ethanol by the embryo was ~ 60 
to 70% of the nominal (solution) concentration across all windows. In general, these data 
suggest that critical periods for heightened sensitivity to developmental ethanol exposure 
vary according to the specific endpoint used to assess toxicity. 
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 Introduction 
Women who consume large amounts of ethanol during pregnancy often give birth 
to children exhibiting phenotypic abnormalities collectively referred to as the Fetal 
Alcohol Syndrome (FAS). These anomalies include growth deficiency, cognitive 
impairment and distinctive craniofacial features (Coles 1993). Ethanol is a well-known 
developmental toxicant in humans and laboratory animals. The primary mechanism for 
the toxic actions of ethanol on the developing organism is, however, unknown (Goodlett 
et al. 2005). Many hypotheses exist, including interaction with neurotrophins (Kentroti 
1997), cell-adhesion molecules (Bearer 2001), or specific receptors (e.g., Costa and 
Guizzetti 2002); as well as increased apoptosis (Olney et al. 2002a; Olney et al. 2002b) or 
oxidative stress (Cohen-Kerem and Koren 2003). Not only are the mechanisms as yet 
unknown (or multifunctional), but the issue of sensitive periods remains largely 
unresolved. That is, it is unclear which stage(s) of development is/are most sensitive to 
ethanol exposure.  
Many investigations have used postnatal development of the rat cerebellum to 
explore temporal variations in developmental ethanol toxicity (Goodlett and Lundahl 
1996; Miki et al. 1999; Pauli et al. 1995; Thomas et al. 1998), whereas others have 
compared late gestational versus early postnatal ethanol exposure (Marcussen et al. 1994; 
Phillips and Cragg 1982). In each case, the Purkinje cells were found to be most sensitive 
to ethanol toxicity during the first 24 to 48 hours of postnatal development. A slightly 
different trend was noted in a study of the trigeminal nerve: these neurons were most 
sensitive to ethanol toxicity during late gestation (when compared to early or late 
postnatal exposures) (Miller 1995). Very few studies have systematically examined 
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 differences in the vulnerability of the entire central nervous system at distinct periods 
throughout brain development. There are primate studies, however, that have compared 
short periods of ethanol exposure early in development with more protracted exposures, 
which included early and late developmental windows. In most cases the short, early 
exposure was as detrimental as the longer, more comprehensive exposure (Clarren et al. 
1992; Schneider et al. 2001). A different pattern was noted in a rat study (Tran et al. 
2000) that compared various windows of ethanol exposure (gestation day 1-10, 11-22 or 
postnatal day 2-10) using brain weight, brain:body weight ratio, motor activity and 
exploratory behavior as measures of toxicity. The authors were also careful to equate 
peak blood ethanol concentrations across all the three exposure periods. In this study, rats 
exposed to ethanol later in development experienced more adverse effects than those 
exposed during the earliest developmental window. As yet, the issue of critical windows 
for developmental ethanol toxicity remains unresolved.  
Fish models offer several advantages over traditional mammalian model systems 
for careful study of developmental timing. Their ex utero development eliminates the 
confounder of maternal toxicity and allows for accurate and precise timing of 
developmental exposures. Fish are susceptible to a range of developmental toxicities, 
including that caused by ethanol. Studies of ethanol-induced toxicity in zebrafish have 
shown that ethanol is a teratogen that produces developmental delays (Reimers et al. 
2004); craniofacial abnormalities (Bilotta et al. 2004; Blader and Strähle 1998; Carvan et 
al. 2004; Loucks and Carvan 2004); skeletal and cardiovascular toxicity (Wang et al. 
2006a); as well as alterations in eye development (Bilotta et al. 2004; Bilotta et al. 2002), 
cell death (Carvan et al. 2004; Loucks and Carvan 2004) and behavior (Carvan et al. 
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 2004). Because fish are vulnerable to ethanol toxicity and develop ex utero, they 
represent a convenient alternative for exploring temporal variations in ethanol sensitivity 
during development. 
I have examined the interaction between developmental toxicity and the timing of 
ethanol exposure using the Japanese medaka fish (Oryzias latipes). The Japanese medaka, 
a small, egg laying, freshwater fish native to Japan, Korea, and eastern China, has been 
widely used in developmental, genetic, and toxicological studies (Gogal et al. 1999; 
Kashiwada et al. 2002; Kelly et al. 1998; Law 2003; Mullins et al. 1994; Wittbrodt et al. 
2002). Medaka are ideal for developmental studies of the interaction between timing and 
toxicity when compared to zebrafish because the length of gestation in zebrafish is 3 
days, compared to 9 days in medaka. This protracted gestation allows for more accurate 
delivery of test compounds during discrete periods of development. In the present studies, 
hatching delays, and growth inhibition were assessed using comparable embryonic 
ethanol concentrations in order to compare differences in developmental ethanol toxicity 
following sublethal ethanol exposures during early [0-3 days post fertilization (dpf), 
middle (3-6 dpf) and late (6-9 dpf) stages of development]. In general, our results suggest 
that medaka embryos are sensitive to ethanol toxicity at all stages of development, 
exhibiting a variable pattern of effects depending upon the window of exposure.  
Materials and Methods  
Test animal, Embryo Collection and Animal Husbandry are as described in 
Chapter 2. 
  45
 Chemicals 
Ethanol (95%), alcohol dehydrogenase and nicotinamide adenine dinucleotide 
were purchased from Sigma-Aldrich (St. Louis, MO). 
Overt Toxicity (Mortality) Study 
Initial range finding studies were performed in order to determine an optimal 
ethanol dosing regimen for induction of developmental toxicity in the absence of embryo 
mortality. Embryos (n=16) were exposed to ethanol (0, 0.1, 0.5, 1.0, 1.5, 2.0, or 3.0%, 
final concentration) (1% ethanol=172 mM) for days 0-8 of gestation, followed by ERM 
only from days 9 to 15; if an embryo had not hatched by day 15 (99%-100% of the 
controls hatch by day 15), then the embryo was scored as ‘not hatched.’ Embryonic death 
was ascertained as described in Chapter 2. All animal husbandry and plate changing 
practices were as described in the Embryo collection and Animal Husbandry section. 
Assessment of the Windows of Vulnerability 
Stage 10 embryos were exposed to varying ethanol concentrations [0, 0.1 (17.2 
mM), 0.5 (86 mM) or 1.0% (172 mM)] during three distinct periods of development (0-3, 
3-6 or 6-9 dpf) (Figs. 3-1; 3-2) in order to investigate the effects of timing and dose on 
ethanol-induced embryo toxicity. Embryos were assessed for treatment-related effects on 
growth, mortality and hatching. Morphometric criteria were evaluated on the day of 
hatching to determine how the timing of ethanol exposure affected medaka growth and 
development. ERM control replicates were also included as a temporal reference of 
normal embryonic development.  
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Figure 3-1: Dorsolateral series of figures showing medaka embryonic development. (A) 
Multi-cell stage embryo at the early high blastula stage [~6.5 hours post 
fertilization (hpf); day 0], the animal pole is five cell layers thick, consisting of 
approximately 1000 blastomeres. (B) Chorionated embryo at stage 29 (~74 hpf; 
Day 3). The embryo has completed axis formation and somite formation; the eyes 
are developing. (C) Chorionated embryo at stage 39 (~ 9 dpf; Day 6). (D) By the 
time embryos are ready to hatch (~Day 9), the tail extends well beyond the 
posterior head region. At this developmental stage, hatching enzyme released from 
the buccal cavity breaks down the inner chorion so that embryos may use their 
body movement to rip through the outer chorion and emerge tail first. Bar = 0.1 
mm. bl = blastula, ch = chorion, ey = eye, hpf = hours post fertilization, od = oil 
droplet, t = tail, y = yolk. 
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 Figure 3-2: Schematic representation of experimental design. To investigate the effects 
of timing and dose on ethanol-induced embryo toxicity, embryos (n=20/dose 
group/window) were exposed within 96-well microtiter plates to a range of 
ethanol concentrations (0, 0.1, 0.5 or 1.0%) in embryo rearing medium during 
three distinct periods of development (e.g., 0-3, 3-6 or 6-9 days post fertilization). 
Fertilized Eggs Collected at Multi-Cell Stage
Exposed to ethanol in embryo rearing
medium for three days during
development
0-3 dpf (early) 3-6 dpf (middle) 6-9 dpf (late)
Four Exposure Conditions:
0% ethanol
0.1% ethanol
0.5 % ethanol
1.0% ethanol
Four Exposure Conditions:
0% ethanol
0.1% ethanol
0.5 % ethanol
1.0% ethanol
Four Exposure Conditions:
0% ethanol
0.1% ethanol
0.5 % ethanol
1.0% ethanol
 
Morphometric Assessment 
Embryos were photographed on the day of hatching using a Nikon SZM 1500 
stereomicroscope and coded for a blinded analysis of the effects of developmental ethanol 
exposure. Linear measures of head width (maximal distance from the lateral aspect of one 
eye to the most lateral aspect of the other) and total body length (distance from the 
rostral-most portion of the head to the caudal most portion of the tail fin) were used to 
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 determine whether developmental ethanol exposure induced a phenotype in fish that is 
qualitatively similar to human fetal alcohol syndrome.  
Determination of Embryonic Ethanol Concentration 
Ethanol exposed and control embryos were washed three times with ERM, 
incubated in 3.5% HClO4 (30 embryos per 90 µl solution) for 1hr at 4°C, sonicated on ice 
and then centrifuged at 2800 x g for 10 min at room temperature. Supernatants were then 
collected for use in an enzymatic reaction between alcohol dehydrogenase and 
nicotinamide adenine dinucleotide. NADH accumulation was determined via the method 
of Reimers et al. (2004) with the following modifications to assure linearity with respect 
to ethanol concentration and incubation time; the concentration of NAD was increased 4x, 
the concentration of alcohol dehydrogenase was decreased 50%, and the assay was 
conducted at 30ΕC instead of 37ΕC. All assays were performed in 96-well microtiter 
plates and NADH accumulation was monitored spectrophotometrically using a 
ThermoMax microplate reader set at 340 nm (Molecular Devices, Sunnyvale, CA). 
Ethanol standards and sample lysates were read kinetically (at 10 second intervals) for 10 
min at 30°C; the slope of the absorbance at 340 nm was used to calculate ethanol 
concentrations. 
Statistical Analyses 
All statistical analyses were conducted using StatView® (Version 5.0.1, SAS 
Institute, Inc.) The two, non-parametric dependent variables (lethality and hatching 
success) were analyzed using an unpaired, Mann-Whitney test. The parametric data (i.e., 
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 length of time the embryo remained in the egg), were analyzed using a global ANOVA 
using day of hatch as the dependent variable, and ethanol dose as the independent 
variable. Any subsequent interactions at the p≤ 0.05 level were followed by step-down 
ANOVAs. When necessary, a Fisher’s PLSD post hoc test was conducted to determine 
differences between ethanol dosage groups. The embryonic ethanol concentration data 
were analyzed with a repeated ANOVA using embryonic and nominal (solution) ethanol 
concentration as the dependent variables, and window of exposure as the independent 
variable.  
Results  
Overt Toxicity 
An initial range-finding study was completed to determine the optimal ethanol 
dosing regimen for induction of developmental toxicity in the absence of embryo 
mortality. Ethanol concentrations at or above 2% were lethal to embryos (defined as an 
opaque egg or the absence of a heartbeat). Embryos exposed to 1% ethanol showed no 
increased lethality. As the above exposures spanned a period of 8 days, a three day dosing 
regimen using 1% ethanol as the highest, non-lethal exposure concentration was adopted 
for subsequent exposures. 
Vulnerable Window Studies 
Length of Gestation (Time to Hatch): There was no interaction between window of 
exposure and ethanol treatment. There was, however, an effect of ethanol treatment (Fig. 
3-3A) and an effect of window of treatment (Fig. 3-3B). Hatching was delayed by at least 
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 one day in embryos treated with the highest concentration of ethanol (1%) (Fig. 3-3A). 
This effect was more pronounced in embryos exposed either from 0-3 or 3-6 dpf when 
compared to embryos exposed from 6-9 dpf.  
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Figure 3-3: Effects of developmental ethanol exposure on time required for hatching. 
Values represent the mean ± sem from two cohorts (total n=20/dose 
group/window). ANOVA analysis revealed that there was no interaction between 
ethanol dose and window of exposure. Panel A: These data are collapsed across 
windows of exposure: only the 1% ethanol exposure delayed hatching. Panel B: 
These data are collapsed across all dosage groups. If two bars have the same 
letter above it, then they are not different from one another. If, however, they have 
different letters above them, then they are different from one another. In this case, 
when embryos were treated during the first two windows, there was delayed 
hatching as compared to no delay if the embryos were treated during the last 
developmental window. Data are presented as a mean ± sem. 
 Head Width: Again, there was no interaction between window of exposure and 
ethanol treatment. All concentrations of ethanol decreased head width compared to 
controls, and this effect was not dependent upon the window of exposure (Fig. 3-4).  
0.0 0.1 0.5 1.0
H
ea
d 
W
id
th
 (m
ic
ro
ns
)
300
400
500
600
**
*
Dose of Ethanol (%)
Window of Exposure
0-3 dpf 3-6 dpf 6-9 dpf
H
ea
d 
W
id
th
 (m
ic
ro
ns
)
300
400
500
600
A. Effect of Ethanol
B. Effect of Window of Exposure
 
Figure 3-4: Effects of developmental ethanol exposure on head width in the newly 
hatched medaka fry. Values represent the mean ± sem from two cohorts (total 
n=20/dose group/window). Ethanol exposure produced dose-related decreases in 
head width that were not correlated with the time of exposure. ANOVA analysis 
revealed that there was no interaction between ethanol dose and window of 
exposure. Panel A: These data are collapsed across windows of exposure: all 
three dose levels of ethanol produced decreased head width. Panel B: These data 
are collapsed across all dosage groups. The window of exposure did not affect the 
decrease in head width. Data are presented as a mean ± sem. 
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 Body Length: For body length, there was an interaction between ethanol effect and 
window of exposure (Fig. 3-5). All three ethanol doses decreased body length if embryos 
were exposed either early (0-3 dpf) or late (6-9 dpf) in development, but this effect was 
only apparent at the highest (1%) dose when ethanol exposure occurred during the middle 
window of development (3-6 dpf). 
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Figure 3-5: Effects of developmental ethanol exposure on total body length of newly 
hatched medaka fry. Values represent the mean ± sem from two cohorts (total 
n=20/dose group/window). Ethanol exposure decreased total body length in a 
dose- and window-of-exposure-dependent fashion, i.e., there was an interaction 
between ethanol dose and window of exposure. The degree of ethanol-induced 
growth inhibition was most severe with high dose exposures that occurred late in 
development. The asterisks indicate a difference between the ethanol dosed group 
and the control for each respective window of exposure. Data are presented as a 
mean ± sem 
Embryonic Concentration of Ethanol During Development: 
The above data outline the toxicodynamic effects of ethanol during three windows 
of development in the medaka fish. In order to determine the concentration of ethanol in 
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 the embryo during these same windows of exposure, embryonic ethanol levels were 
assessed after exposure to 1% ethanol. Embryos took up roughly the same amount of 
ethanol regardless of developmental stage (Fig. 3-6).  
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Figure 3-6. Determination of ethanol dose. The embryonic ethanol dose was 
assessed after a 3-day exposure to 1% ethanol in embryo rearing medium during early, 
middle and late development; the solutions were renewed daily. Nominal and 
embryonic ethanol concentrations were determined (n=3 pools of 30 embryos each). 
Data are presented as the mean ± sem. Although ANOVA analysis revealed the 
nominal and embryonic ethanol concentrations to be different from one another, the 
amount of ethanol taken up by the embryo at each age window was not different 
depending on the age of the embryo. 
 
The amount of ethanol that enters the embryo after three days of exposure to 1% 
ethanol (changing solutions every day) is approximately 60%-70% (grey bars, Fig. 3-6) of 
the nominal concentration of the ethanol solution contained in the well. Moreover, the 
concentration present in the solution surrounding the embryo did not decrease from the 
  55
 original amount (1%) which was added to the well ~24 hours before test samples were 
taken (black bars in Fig. 3-6).  
Discussion 
Most FAS studies focus on isolated events that occur within one specific stage of 
development and/or to one specific group of cells or neurons. Few investigators have 
examined the global effects incurred when ethanol administration is strictly partitioned 
within the confines of specific stages of development. The literature seems to suggest 
multiple effects on multiple systems with no clear indication of whether early or late 
ethanol exposure is more deleterious to the developing embryo. 
The present studies used the extended duration of medaka embryonic development 
to assess temporal variations in developmental ethanol toxicity. Table 3-1 shows that, in 
general, no developmental window is the least or most sensitive, rather the pattern of 
effects depends upon the endpoint examined. If ethanol exposure occurred early in 
development (0-3 dpf), embryos were extremely sensitive to reduced head width and total 
body length. A similar pattern was observed when the embryos were exposed late in 
development (6-9 dpf). Embryos exposed to ethanol during the middle interval of 
development (3-6 dpf), however, appeared less responsive to ethanol-induced decreases 
in total body length and equally responsive to ethanol-induced decreases in head width. 
Interestingly, some measures, (e.g., head width), are changed at all doses and all windows 
of exposure, whereas others (e.g., total body length) are highly sensitive to the window of 
exposure.  
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Window of Exposure 
Endpoint 
0-3 dpf 3-6 dpf 6-9 dpf 
Gestational Length 
(Hatching) 
? only at highest 
ethanol dose 
? only at highest 
ethanol dose 
No effect 
Head Width 
 
? at all doses 
 
? at all doses 
 
?at all doses 
Body Length 
 
? at all doses 
 
? only at highest 
ethanol dose 
 
?at all doses 
Embryonic [Ethanol] 60% of nominal 66% of nominal 69% of nominal
Table 3-1: Summary of Data from Chapter 3. Data presented in the grey shaded region is 
from animals treated only with 1% ethanol. 
 
To put these changes in perspective, one can compare the results in Table 3-1 with 
known effects of ethanol on mammalian development. In humans, ethanol exposure 
during gestation produces persistent decreases in height and head circumference (Habbick 
et al. 1998; Sokol and Clarren 1989). These parameters are generally considered to be the 
most sensitive diagnostics for ethanol-induced intrauterine growth restriction (Streissguth 
et al. 1991). This treatment effect was also observed in the present study, which showed 
ethanol–induced deficits in total body length and head width even at the lowest ethanol 
concentration (0.1%; nominal).  
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 Comparison of the present data on ethanol toxicity in medaka with previously 
published studies of ethanol toxicity in fish shows some similarities and some differences. 
The dose of ethanol producing overt toxicity (i.e., 2% ethanol) is very similar to that 
noted in other studies. Wang and coworkers estimated the 48 hour LC50 for ethanol 
exposure in medaka embryos to be ~3.2% (Wang et al. 2006a), which is comparable to 
the present lethal dose calculation of ~2% for an 8 day exposure. The zebrafish literature 
indicates that sensitivity to ethanol lethality is strain dependent (Loucks and Carvan 
2004), with the three day (i.e., embryonic) LC50 hovering around 1.7 to 2.0% (Loucks and 
Carvan 2004; Reimers et al. 2004). There is disagreement, however, regarding how much 
ethanol enters the embryo. Although Blader and Strähle (1998) assumed that 100% of the 
nominal (i.e., media) ethanol concentration reached the zebrafish embryo because the rate 
of cyclopia was the same both in chorionated and dechorionated embryos, later 
assessments of the intra-embryonic ethanol dose was estimated to be only 30% of the 
nominal ethanol concentration in zebrafish (Reimers et al. 2004) or 20% of the nominal 
ethanol concentration in medaka (Wang et al. 2006a). These findings are contrasted by 
the present data which indicate that approximately 60-70% of the waterborne ethanol 
concentration enters the embryo. These differences could be due to the longer exposure 
interval (3 days) used in the present study or to our optimization of the enzymatic assay 
used for ethanol determinations.  
Central nervous system structures are heterogeneous, with individual neurons 
developing on different timescales that vary considerably across brain regions and 
neuronal populations. If the mechanism of ethanol toxicity is not specific for the type of 
neuron affected, but instead dependent upon the precise stage of neuronal development, 
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 this may explain the lack of specificity observed with ethanol related developmental 
effects. The more homogenous an experimental system is, the more likely a critical 
window for ethanol toxicity may be identified, but as the system becomes more 
heterogeneous (as in the entire brain), the temporal effects of ethanol toxicity are going to 
appear multifaceted and diffuse. 
In his comprehensive review of critical windows for developmental ethanol 
toxicity, (West 1987) concluded that the human third trimester equivalent appeared to be 
most sensitive to developmental ethanol toxicity. That conclusion is confounded by (1) 
the lack of standardization with regard to blood ethanol concentrations and (2) the lack of 
available information regarding temporal sensitivity, as very few investigators have 
compared the differential effects of ethanol toxicity when peak blood ethanol 
concentrations are equated across all three trimesters of development. In fact, West later 
goes on to suggest that the human third trimester equivalent may simply appear more 
sensitive to developmental ethanol toxicity because, in general, the blood ethanol 
concentrations tended to be higher when animals were exposed during this developmental 
window. In the present study, I have addressed many of these issues by conducting a side 
by side comparison of different developmental windows while maintaining a comparable 
ethanol body burden in the embryo. Our general conclusion echoes the conclusions of 
(West 1987) and (Tran et al. 2000); ethanol is toxic at all developmental windows, but if 
a single window must be chosen, then the last exposure window appears more sensitive.
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 CHAPTER 4. 
EFFECT OF ETHANOL ON THE DEVELOPMENT OF THE NERVOUS SYSTEM OF 
THE MEDAKA: WINDOWS OF SENSITIVITY 
Preface 
Work described in this chapter relates primarily to Aim 3. Medaka embryos 
exhibited dose-related decreases in head width and brain volume as a result of 
developmental ethanol exposure. Ethanol-induced increases in programmed cell death 
have been implicated in microencephaly associated with FAS, therefore, these 
experiments specifically addressed caspase-3/7 activation as a potential mechanism of 
ethanol-related decreases in brain growth. Although ethanol-induced decreases in brain 
volume were most pronounced with early or late developmental exposures, treatment-
related changes in caspase-3/7 activation did not vary with the timing of exposure. These 
studies revealed that developmental ethanol exposure inhibits normal increases in 
caspase-3/7 activation that occur naturally during development, indicating that increased 
cell death may not be the primary mechanism for ethanol-induced decreases in brain size.  
  
 Abstract 
Ethanol-related defects in CNS morphogenesis may precipitate a number of 
teratogenic events, including microencephaly and mental retardation. Ethanol-induced 
increases in programmed cell death (apoptosis) may contribute to CNS insufficiency. In 
this study, medaka embryo toxicity tests were used to investigate temporal changes in 
ethanol-induced activation of the apoptotic executor, caspase-3/7. Two exposure 
paradigms were used for this evaluation. In the first cohort, control and 1% ethanol 
treated embryos were assessed for caspase-3/7 activation sequentially (e.g., every 24 hrs) 
throughout gestation. In the second cohort, embryos were exposed to 1% ethanol during 
early (0-3 dpf), middle (3-6 dpf) or late (6-9 dpf) gestation and assessed for changes in 
caspase-3/7 activation on day 9 post fertilization. Increases in caspase-3/7 activation were 
noted in embryos treated on days 1 or 2 (early), whereas decreases were seen in embryos 
treated on day 6 (middle) or day 8 (late). When the duration of exposure was increased to 
72 hrs and embryos were subsequently assessed on day 9, there was a substantial effect of 
ethanol exposure, but no effect of developmental timing. Marked decreases in caspase-3/7 
activity were observed for all windows of exposure. Ethanol appeared to blunt the 
increase in caspase-3/7 activity that occurs naturally during embryonic development, 
suggesting that developmental ethanol exposure may not exert its morphogenic effects via 
increased apoptosis.  
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 Introduction 
Although dysmorphic effects are commonly seen in FAS, ethanol-induced changes 
in CNS development may occur without concomitant deformity. “Alcohol-related 
neurodevelopmental disorders” (ARND) is a term used to describe individuals who 
experience mental and physical impairments as a result of prenatal ethanol exposure (in 
the absence of craniofacial malformations). These neurodevelopmental effects are often 
as severe as those seen with full blown FAS (Mattson et al. 1994).  
There is no doubt that ethanol adversely affects brain development. Humans and 
experimental animals exposed to ethanol during gestation exhibit permanent deficits in CNS 
structure. Post mortem (Clarren 1981; Clarren et al. 1978; Peiffer et al. 1979) and brain 
imaging [(Mattson et al. 1996; Ronen and Andrews 1991); and reviewed in Roebuck et al. 
1998] studies have confirmed malformations in brains of children exposed to ethanol in 
utero. Microencephaly was the most consistent finding, with FAS patients showing 
substantial reductions in brain volume relative to controls (Archibald et al. 2001; Sowell et 
al. 1996). Rodent models have also been valuable for demonstrating region-specific 
manifestations of developmental ethanol toxicity in vivo (Kotch and Sulik 1992; Webster et 
al. 1983; West 1987). Animal studies have unveiled a number of forebrain deficiencies 
following prenatal ethanol exposure (Ashwell and Zhang 1994; Maier et al. 1999a; Maier et 
al. 1999b; Webster et al. 1980).  
Very few investigators have compared ethanol-induced changes in brain volume or 
brain weight during discrete periods that encompass early, middle or late development. 
The most comprehensive and well-controlled study with regard to BEC was conducted 6 
years ago by Tran and coworkers (Tran et al. 2000). They found that rats exposed to 
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 ethanol during GD 11-22 or PD 2-10 experienced decreases in brain weight, whereas 
those exposed during the earliest developmental window (GD 1-10) did not. As depressed 
brain volume/weight appears to be a common result of developmental ethanol exposure in 
humans, and laboratory animals exhibit regional differences in ethanol-induced inhibition 
of brain growth, I wanted to determine (1) if developmental ethanol exposure decreases 
brain volume in medaka embryos; (2) if temporal variations in ethanol-induced inhibition 
of brain growth coincide with a specific exposure window and (3) if treatment-related 
changes in brain volume correlate with changes in the apoptotic indicator, caspase-3/7. 
Temporal variations in ethanol-induced inhibition of somatic growth were demonstrated 
in Chapter 3. This chapter investigated a neurodevelopmental endpoint that is known to 
be affected by developmental ethanol exposure. Specifically, ethanol-induced changes in 
brain growth were assessed in order to determine whether medaka embryos experience 
spatiotemporal variations in developmental ethanol toxicity.  
Materials and Methods 
Chemicals 
Chemicals were as described in Chapter 3  
Test animal  
Japanese medaka embryos used in this study were collected from an orange-red 
line maintained under standard re-circulating aquaculture conditions. See Chapter 3 for a 
detailed description. 
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 Research design 
Research design was as described in Chapter 3 except that the embryos were 
exposed to either 0 or 1% ethanol during different windows of development. The lower 
concentrations of ethanol were not used.  
Fixation and Histological Procedures 
On the day of hatching, control and treated fry were anesthetized in ice-cold ERM 
and fixed in 4% paraformaldehyde/phosphate buffered saline (PBS; pH 7.4) for 48 hrs at 
4°C. Specimen were stored in 6% sucrose/PBS (pH 7.4) at 4°C until mounting and 
sectioning. Hatched fry were oriented vertically with the rostral portion down and double 
embedded in paraffin. Each block of paraffin contained a control and a treated animal 
from each exposure window. Coronal step sections (5 µm thickness) taken throughout the 
brain were then mounted on glass slides and stained with hematoxylin and eosin for 
neuroanatomical assessment. In practice, approximately 70-80 sections were sufficient to 
image the forebrain, midbrain and rostral portions of the hindbrain. Coronal sections were 
terminated at the point where separation between ventral and dorsal hindbrain regions 
was no longer apparent. The intestinal bulb and liver was also visible in these sections. 
Images were captured with a Nikon Eclipse TE 200 stereomicroscope, and Spot 
Advanced imaging software. 
Estimates of Brain Volumes 
All hematoxylin and eosin stained sections were photographed using a 20x 
objective and printed. The area of each brain section was estimated using the Cavalieri 
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 method (Howard and Reed 1998). Briefly, a 15 x 20 grid was randomly placed over the 
section and all the intersections that fell within the forebrain were counted. The volume 
of the brain was calculated as the sum of the areas of the sections (taking into 
consideration the size of the grid and the magnification) times the thickness of the 
sections, assuming a 5 micron nominal thickness of each section. In cases of missing 
sections, the volume of the absent region was estimated from adjacent sections using the 
formula for the volume of a truncated cone: 
2
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NMS = number of missing sections 
AAdj1 = area of one adjacent section 
AAdj1 = area of the other adjacent section.  
 
To ensure consistency in determining the rostral-caudal boundaries for volume 
estimates, landmarks were used (Anken and Bourrat 1998). The rostral brain landmark 
was the ventral telencephalon; the caudal landmark of the brain was the caudal extent of 
the inferior lobule. The volume of the rostral and caudal halves of each brain were 
calculated as the brain volume of the first half of the sections and the volume of the 
caudal half was calculated from the caudal half of the sections.  
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 Caspase Activity 
Embryos at each age were treated with 1% ethanol for 24 hours. At the end of this 
exposure period, groups of embryos were homogenized (n=6 pools of 10 embryos at each 
age; 10 embryos per 100µL) in lysis buffer (10 mM HEPES, 42 mM KCl, 5 mM MgCl2, 1 
mM dithiothreotol, 0.1 mM EDTA, 0.1 mM EGTA; pH 7.4) and centrifuged at 2800 x g 
for 20 min at 4°C. Supernatants were aliquoted and stored at -80°C until analysis. 
Caspase activation was measured as the release of aminoluciferin from a selective 
substrate for caspase-3/7 (Z-DEVD-AML) using the Caspase-Glo 3/7® Luminescence 
Assay kit (Promega, Madison, WI). Luminescence was determined using a FLUOstar 
Optima luminometer. The assay was optimized so that caspase-3/7 activity was linear 
with respect to protein concentration and incubation time. On the day of assessment, all 
samples were thawed on ice and 10 µl of the sample lysate (~30 µg protein) was added to 
90µl of the Caspase-Glo substrate and incubated in the dark for 1 hr at room temperature. 
Purified caspase-3 enzyme (Biomol #SE-169, Plymouth Meeting, PA.) was included as a 
positive control, and addition of the specific caspase-3 inhibitor, AC-DEVD-CHO 
(Calbiochem) was used to show that approximately 90% of the observed luminescence 
was due to caspase-3 activity (data not shown).  
Statistical Analyses 
All statistical analyses were done using StatView® (version 5.0.1), and all data 
are presented as mean ± standard error of the mean. The brain volumes were first 
compared using a global (repeated) ANOVA with total, rostral and caudal brain volume 
as the dependent variables and treatment (ethanol or control) or window (control, 0-3, 3-
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 6, or 6-9 dpf) as the independent variables. If the interaction between endpoint and 
treatment or window of treatment was p≤ 0.10, then a step down ANOVA was performed 
for each type of volume estimate. If that ANOVA was significant at the p≤ 0.05 level, 
then a Fisher’s PLSD post hoc test was conducted to determine which window of 
treatment was different from the controls. 
Caspase data collected during embryogenesis were analyzed using a global 
ANOVA with caspase activity as the dependent variable and age of the embryo and 
ethanol exposure as the independent variables. A Fisher’s PLSD post hoc test was 
conducted to determine differences between the ethanol treated and control groups. The 
caspase data assessed on day 9 were first compared by ANOVA to determine if there was 
an overall effect of treatment: ethanol treated vs. control groups. If the p≤ 0.10, then a 
second, step-down ANOVA was conducted to determine if there was an effect of window 
of treatment, using window of treatment as the independent variable and caspase activity 
at day 9 as the dependent variable. If the p≤ 0.05, then between groups comparisions were 
conducted using a Fisher’s PLSD test. 
Results 
Figures 4-1 and 4-2 show coronal sections of the newly hatched fry brain at two 
different anatomical levels. The optic chiasm level (Fig. 4-1) is representative of the 
rostral brain and the optic tectum level (Fig. 4-2) is representative of the caudal mid-
brain. Each figure shows representative sections from all treatment groups. When 
comparing coronal brain sections it was very difficult to identify specific treatment-
related effects due to variability in section orientation. Assessments were further  
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Figure 4-1: Coronal Sections of the Rostral Brain in the Medaka Fry at the Level of the 
Optic Chiasm. Medaka were treated with 1% ethanol during the three windows of 
development (0-3 dpf, 3-6 dpf, or 6-9 dpf). On the day of hatching (usually day 
10), the medaka were fixed and later embedded in paraffin for histological 
assessment. 
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 complicated by the fact that there is no atlas for the medaka fry brain, requiring that many 
structures be inferred using the atlas for the adult medaka brain (Anken and Bourrat 1998). 
As examination of individual sections did not provide any consistent treatment-related 
patterns, I then used these sections to calculate total brain volume, which ranged from 
~150,000 – 300,000 cubic microns in treated and control animals, respectively. 
 
Figure 4-2: Coronal Sections of the Caudal Mid-Brain in the Medaka Fry at the Level 
of the Optic Tectum. Medaka embryos were treated with 1% ethanol during the 
three windows of development (0-3 dpf, 3-6 dpf, or 6-9 dpf). On the day of 
hatching (usually day 10), the medaka were fixed and later embedded in paraffin 
for histological assessment. 
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 Treatment with 1% ethanol during different windows of gestation produced 
profound effects on brain volume in the newly-hatched fry (Figs. 4-3 and 4-4), and 
observed decreases in brain volume were dependent upon both the window of exposure 
(Fig. 4-3) and the area of the brain being assessed (Fig. 4-4). Medaka embryos treated 
with 1% ethanol during early (0-3dpf) or late (6-9 dpf) development experienced 
decreases in total brain volume (Fig. 4-3), whereas embryos treated during mid-gestation 
(3-6 dpf) did not. Interestingly, the effect of ethanol was much more pronounced in the 
rostral portion of the brain (Fig. 4-4) when compared to the caudal portion (Fig. 4-4) of 
the brain. In the rostral portion of the brain, the pattern of effect mimicked what was seen 
in the entire brain (Fig. 4-3) with the first and last exposure windows showing decreased 
brain volume and the middle exposure window showing no effect. This is contrasted by 
the pattern of effect noted in the caudal portion of the brain, where animals treated during 
the first window (0-3 dpf) showed an effect on brain volume, whereas animals treated 
during the second (3-6 dpf) or third (6-9 dpf) developmental windows did not.  
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Figure 4-3: Comparison of the brain volume of the medaka fry treated with ethanol 
during the three windows of development. Medaka were treated with 1% ethanol 
during the three windows of development (0-3 dpf, 3-6 dpf, or 6-9 dpf). On the day 
of hatch (usually day 10), the medaka were fixed and later embedded in paraffin 
for histological assessment. Volume was calculated from areal point counts using 
stereological techniques. An overall ANOVA indicated that there was a main effect 
of ethanol treatment (see figure), and an effect of window of treatment. * indicates 
that the ethanol treated group is different from the control group (p≤ 0.05). Data 
are presented as the mean ± standard error of the mean. n=4, except for the 0-3 
dpf treated embryos where the n=2 
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Figure 4-4: Comparison of the rostral and caudal half of brain volume in medaka fry 
treated with ethanol during the three windows of development. Medaka were 
treated with 1% ethanol during the three windows of development (0-3 dpf, 3-6 
dpf, and 6-9 dpf). On the day of hatch (usually day 10), the medaka were fixed and 
later embedded in paraffin for histological assessment. Volume was calculated 
using stereological techniques. An overall ANOVA indicated that there was a main 
effect of ethanol treatment, and an effect of window of treatment. * indicates that 
the ethanol treated group is different from the control group (p≤ 0.05). Data are 
presented as the mean ± standard error of the mean. n=4, except for the 0-3 dpf 
treated embryos where the n=2.  
  73
 Caspase-3/7 Activity 
Under normal conditions, caspase-3/7 activity in the medaka embryo increases 
dramatically within the first seven days of embryonic development, exhibiting an 18 fold 
increase in activity between days 1 and 9 post fertilization (Fig. 4-5A). Interestingly, 
there were two plateaus in caspase-3/7 activity that occurred between 3-4 dpf and then 
again between 6-7 dpf (Fig.4-5A). During the first three days of development, caspase-3/7 
activity increased approximately 2-fold, and then increased more than 3-fold between 4-6 
dpf. This was followed by a 2.5 fold increase in caspase-3/7 activity that occurred during 
the last three days of development (6-9 dpf) (Fig. 4-5A). A brief, 24 hour treatment with 
1% ethanol produced differential effects on caspase-3/7 activity depending upon the 
timing of exposure; data are presented in blocks of three days due to differences in the 
magnitude (scale) of caspase activity. For example, if embryos were treated with ethanol 
on days 1 or 2 post fertilization, there was an increase in caspase-3/7 activity (Fig. 4-5B); 
however if embryos were treated with 1% ethanol on day 6 post fertilization, there was a 
substantial decrease in caspase-3/7 activity (Fig. 4-5C), and if embryos were treated on 
day 8 post fertilization, a more attenuated decrease in caspase 3/7 activity was observed 
(Fig. 4-5D).  
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Figure 4-5: Caspase-3/7 activity in the developing medaka embryo (upper panel) and the 
effects of developmental ethanol exposure on caspase-3/7 activity (lower three 
panels; note that the y axes are different on the lower three panels). Values 
represent the mean response from three cohorts (total n=6; each observation was 
a pool of 10 embryos). A single 24 hr exposure to 1% ethanol induced reciprocal 
effects on caspase-3/7 activity depending upon the timing of exposure. Early 
developmental ethanol exposure increased and later developmental ethanol 
exposure decreased caspase-3/7 activity. Data are presented as a mean ± sem. An 
overall ANOVA indicated that there was a main effect of ethanol treatment and a 
main effect of age of the embryos and an interaction between the two. Step-down 
ANOVAs comparing the caspase-3/7 activity for each age embryo revealed 
differences at days 1, 2, 6 and 8 post fertilization. * indicates that the ethanol 
treated group is different from the age-matched control (p≤ 0.05). The control 
data in the upper panel and the lower panels are identical.  
Treatment with 1% ethanol for three days during the first (0-3 dpf), second (3-6 
dpf) or third (6-9 dpf) developmental window with an assessment of whole embryo 
caspase activity on day 9 produced a different pattern of effect. In this case, there was a 
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 marked decrease in caspase activity in treated embryos relative to controls, regardless of 
the window of exposure (Fig. 4-6).  
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Figure 4-6: Caspase-3/7 activity in the medaka embryo on Day 9 of development, right 
before hatching. Each group of embryos was treated with 1% ethanol during the 
three windows of embryonic development: first (0-3 dpf), middle (3-6 dpf) or late 
(6-9 dpf). Then on day 9 post fertilization, whole body caspase-3/7 activity was 
assessed. Ethanol treatment during all windows produced a profound decrease in 
caspase-3/7 activity. An overall ANOVA indicated that there was a main effect of 
ethanol treatment, but no window x treatment interaction. * indicates that the 
ethanol treated group is different from the control group (p≤ 0.05). Data are 
presented as a mean ± sem. Values represent the mean response from n=6; each 
observation was a pool of 10 embryos 
Discussion 
The literature shows that developmental ethanol exposure produces permanent 
changes in brain structure and differentially affects specific cell populations and brain 
regions, but information regarding the spatiotemporal effects of developmental ethanol 
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 exposure is sparse, both in humans and in experimental animals. Research presented in 
this chapter addressed the relationship between timing and toxicity by examining 
spatiotemporal variations in the observed manifestations of developmental ethanol 
toxicity in medaka fish.  
Our primary objective was to determine whether developmental ethanol exposure 
produced decreases in medaka brain size, as previously noted in humans and experimental 
animals. The second objective of these studies was to identify the most sensitive period 
for ethanol-induced decreases in brain volume. These results indicate that embryonic 
exposure to 1% ethanol during discrete periods of development causes profound 
decreases in brain volume (Fig 4-3). Specifically, developmental ethanol exposure 
produced decrements in brain growth that were most severe with treatment occurring 
either during early or late development (Fig. 4-3). Although these findings are consistent 
with a number of reports indicating ethanol-induced decreases in total brain 
volume/weight (Archibald et al. 2001; Ashwell and Zhang 1994; Chen et al. 1998; Maier 
et al. 1999a; Maier et al. 1999b; Sowell et al. 1996), they differ somewhat from those of 
Tran and coworkers, who observed marked inhibitory effects on brain weight with middle 
or late, but not early ethanol exposure (Tran et al. 2000). This disparity may reflect 
procedural differences, as this research group used an ethanol dose that was 
approximately 50% of that used in the present study. Developmental ethanol exposure 
also exerted region-specific effects on embryonic brain growth (Fig. 4-3). Substantial 
decreases in total brain volume were observed in treated embryos relative to controls with 
a disproportionate reduction in rostral brain regions (Fig. 4-4). This finding is consistent 
with previous reports of hypoplastic forebrain development in humans (Mattson et al. 
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 1994), as well as mouse (Ashwell and Zhang 1994) and avian (Cartwright and Smith 
1995) models of FAS.  
In contrast to the enhanced sensitivity observed with early or late ethanol 
exposure, embryos treated during the middle developmental window appeared less 
responsive to developmental ethanol toxicity. This treatment group was relatively 
resistant to ethanol-induced decreases in brain volume and structural integrity. A similar 
pattern of ethanol sensitivity was described in Chapter 3, wherein embryos treated during 
3-6 dpf were less affected by ethanol-induced decreases in somatic growth (Table 3-1) 
than those treated during early or late development. At this point, it is unclear why this 
treatment group remained largely unaffected by developmental ethanol exposure, but it is 
possible that temporal differences in gene expression may confer susceptibility or 
resistance to ethanol toxicity at various stages of development (Dunty et al. 2001). 
Regional differences in patterning genes that are essential for morphogenesis, including 
members of the Hox family (Trainor and Krumlauf 2000), may influence spatiotemporal 
aspects of developmental ethanol toxicity. Phenotypic similarities between ethanol-
exposed and Hox -/- embryos suggest that these genes may be selectively targeted by 
ethanol (Barrow et al. 2000). In addition, (Dupe and Lumsden 2001) have shown that the 
dependency on signaling morphogens is progressively lost in a rostral-to-caudal fashion 
as neurodevelopment proceeds. This could partially explain the enhanced sensitivity 
observed with early ethanol exposure, but does not account for the relative insensitivity 
observed with later exposures.  
No single mechanism can account for all of the adverse effects observed in FAS, 
but animal models have identified several possibilities, many of which precipitate cell 
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 death by apoptosis or necrosis. These include ischemia, oxidative stress and subsequent 
mitochondrial damage, interference with growth factor and second messenger function, 
decreased protein synthesis, insufficient nutrient utilization, abnormal glucose 
metabolism, altered prostaglandin homeostasis, depletion of energy stores and aberrant 
cell cycle kinetics (Abel and Hannigan 1995; Guerri et al. 1984; Maier et al. 1996; 
Phillips and Cragg 1982; Santillano et al. 2005; Schenker et al. 1990; West et al. 1994). 
Our initial data seemed to support changes in apoptosis as a potential mechanism of 
developmental ethanol toxicity. When embryos were treated with 1% ethanol and 
caspase-3/7 activity was measured after 24 hours of exposure, there were changes in 
caspase-3/7 activity regardless of the window of exposure. Increased caspase activation 
was noted if embryos were exposed to ethanol on days 1 or 2 of development, however, if 
the same exposure occurred on day 6 or day 8, substantial decreases in caspase-3/7 
activity were noted. Interestingly, when embryos were exposed to ethanol for 72 hours 
during early, middle or late development and caspase-3/7 activity was subsequently 
assessed on day 9 (immediately before hatching), all three treatment groups showed 
marked decreases in caspase-3/7 activity regardless of the window of exposure. Although 
an increase in caspase-3/7 activity was expected (indicatng treatment-related increases in 
apoptosis), there was actually a decrease in whole embryo caspase activity following 
developmental ethanol exposure, suggesting that apoptotic cell death may not be the 
primary mechanism for ethanol-induced growth retardation in this particular model.  
While it is generally well-accepted that an increase in caspase-3/7 activity 
signifies an increase in apoptosis, it is becoming increasingly clear that this view may be 
too simplistic. For example, caspase-3/7 can exert non-apoptotic effects on cellular 
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 differentiation [(Ishizaki et al. 1998); for recent reviews see Abraham and Shaham 2004; 
Launay et al. 2005; Sehra and Dent 2006]. Our results are consistent with a recent report 
of decreased caspase-3 activity in rat pancreas following developmental ethanol exposure 
(Wang et al. 2006b). Although changes in caspase-3 activity are often viewed in terms of 
apoptotic potential, an alternative explanation for treatment-related changes in enzyme 
activity could be dysregulation of the developmental differentiation profile of the embryo. 
As mentioned above, the developmental effects of ethanol exposure include changes in 
differentiation and cell cycle kinetics. Since these processes are highly integrated, one 
could speculate that ethanol interference with caspase signaling is mediated by an 
inherent variability in the extent of programmed cell death that occurs naturally at 
different developmental stages. It is important to note that the present results are not 
exclusively related to CNS deficits, as the caspase activity measured here is whole 
embryo caspase activity and not confined specifically to the nervous system. With an axis 
of development, however, it is likely that a major portion of the measured caspase activity 
is related to the central or peripheral nervous system. 
Defining critical windows for ethanol-induced brain injury is important for the 
rational design of novel neuroprotective strategies which may reduce the burden of 
abnormal neurodevelopment. This study demonstrates the responsiveness of medaka 
embryos to ethanol-induced inhibition of brain growth. Temporal and regional differences 
in this inhibitory effect were observed, indicating that the medaka CNS is highly sensitive 
to developmental ethanol toxicity. Brain volume was significantly decreased with ethanol 
exposure during early or late development, with embryos treated during mid-gestation 
remaining largely unaffected. This may reflect protective influences that effectively offset 
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 CNS damage during this particular window of development. In addition, forebrain regions 
appeared more sensitive than hindbrain regions, though this treatment effect was not 
immediately apparent when viewing individual sections. Taken together, these findings 
indicate that the timing of gestational insult is a major determinant of developmental 
outcome in medaka embryos.  
Table 4-1: Summary of Results for Chapter 4. 
 
 
Window of Exposure Endpoint 
0-3 dpf 3-6 dpf 6-9 dpf 
Caspase-3/7 Activity  
During Embryonic 
Development 
 
 
?14% on Day 1 
?26% on Day 2 
 
 
? 42% on Day 6 
 
? 22% on Day 8
Caspase-3/7 Activity 
Immediately Before 
Hatching (Day 9 pf) 
? ? ? 
Total Brain Volume ?  ? 
Rostral Brain Volume ?  ? 
Caudal Brain Volume ?   
 
 
  81
 CHAPTER 5.  
GENERAL DISCUSSION 
Review of Accomplishments  
This dissertation addressed the hypothesis that developmental ethanol exposure 
produces a phenotype in medaka that (1) varies depending upon the timing of exposure 
and (2) is qualitatively similar to human FAS.  Ethanol-induced growth suppression is a 
common consequence of developmental ethanol exposure in mammalian systems and 
research described in this thesis shows that medaka embryos exhibit a similar response, 
demonstrating the sensitivity of the medaka early life stage assay for assessing 
developmental ethanol toxicity.  
Morphometric data presented in Chapter 3 indicate dose-related decrements in 
brain and somatic growth which varied according to the precise timing of developmental 
ethanol exposure.  Several parameters were initially chosen to assess ethanol effects on 
medaka growth and development, including measures of head width, head length, mouth 
length, neck width and total body length. Results from these investigations were 
consistent with human studies, which indicate that head width and total body length are 
the most sensitive growth parameters for assessments of developmental ethanol toxicity.  
 Approximately 60-70% of the nominal ethanol concentration was detected in 
treated embryos, suggesting that the intra-embryonic ethanol doses achieved in these 
  
 studies ranged from approximately 11.6 - 116 mM. Since it is unlikely that the outer 
chorion significantly restricts ethanol diffusion, these numbers should have been closer to 
100%. In theory, other factors, such as embryonic metabolism or enhanced permeability 
due to acid washes may serve to limit ethanol analyses. 
Despite extensive research on the adverse effects of developmental ethanol 
exposure, information regarding potential interactions between timing and toxicity is 
fairly limited.  The medaka early life stage test was used to examine temporal variations 
in developmental ethanol toxicity and identify the critical period(s) for enhanced 
susceptibility. In order to investigate potential “windows” of heightened sensitivity, 
embryos were exposed to a range of ethanol concentrations during early, middle or late 
development and assessed for treatment-related effects on various measures of overt 
toxicity (e.g., growth, hatching) and neurotoxicity (brain volume) (see Table 5-1 for a 
summary of the results). Hatching delays were found to be relatively insensitive to 
developmental ethanol exposure, exhibiting treatment effects only at the highest ethanol 
dose. Head width, a highly sensitive measure of ethanol toxicity, was decreased at all 
doses, regardless of the timing of exposure.  Interestingly, the temporal pattern of ethanol 
sensitivity for treatment-related changes in brain volume and total body length appear to 
overlap, as decreases in both endpoints were observed when ethanol exposure occurred 
during the first or last developmental windows. 
Assessments of caspase-3/7 activity were used to investigate treatment-related 
changes in apoptotic potential.  These studies showed that ethanol exposure exerts 
differential effects on caspase-3/7 activity depending upon the window of exposure.  
Results obtained when caspase activity was measured sequentially throughout 
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 development revealed increased caspase activation with early exposure (days 1 or 2 post 
fertilization) and decreased caspase activation with later ethanol exposure (days 6 or 8 
post fertilization). When assessed on day 9 post-fertilization (after 72 hrs of ethanol 
exposure during early, middle or late development), however, comparable decreases in 
caspase activity were observed across all windows of exposure. Since there was no effect 
of window and a decrease in caspase activity was observed (instead of the expected 
increase), these results raise many questions regarding possible modes of action which 
require additional research. 
Table 5-1: Summary of All Results by Window of Exposure 
 
Window of Exposure Endpoint 
0-3 dpf 3-6 dpf 6-9 dpf 
Gestational Length 
(Hatching) 
? only at highest
ethanol dose 
? only at highest 
ethanol dose 
No effect 
Head Width  ? at all doses 
 
? at all doses 
 
?at all doses 
Body Length 
 
? at all doses 
 
? only at highest 
ethanol dose 
 
?at all doses 
Caspase 3/7 Activity  
During Embryonic 
Development 
 
 
?14% on Day 1
?26% on Day 2
 
 
? 42% on Day 6 
 
? 22% on Day 8
Caspase-3/7 Activity 
Immediately Before 
Hatching (Day 9 pf) 
? ? ? 
Total Brain Volume ?  ? 
Rostral Brain Volume ?  ? 
Caudal Brain Volume ?   
Embryonic [Ethanol] 60% of nominal 66% of nominal 69% of nominal 
 
Data in the shaded region represent exposure to only 1% ethanol. 
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 General Discussion  
“A bewildering number of possibilities...” this was the consensus regarding 
potential mechanisms for developmental ethanol toxicity two decades ago and it remains 
largely unchanged today. A wide range of hypotheses have been proposed for the 
teratogenic effects of developmental ethanol exposure, but as yet, no primary mechanism 
has been identified with any certainty. In many ways, the field is still wide open, as 
researchers continue to identify new targets within the complex spectrum of effects 
associated with prenatal ethanol exposure. The current state of evidence regarding 
developmental ethanol toxicity seems to indicate multiple effects on multiple systems 
with no real indication of whether early or late ethanol exposure is more hazardous to the 
developing embryo (Table 5-1). 
Results obtained in the present study lend support to this notion. I have used 
medaka embryos to investigate temporal variations in developmental ethanol toxicity and 
my findings suggest that there is no finite period in development that is most or least 
sensitive to ethanol. Given the complexity and precision of events required for normal 
development, a logical assumption might be that the critical interval for developmental 
ethanol exposure is widespread, manifesting various degrees of toxicity depending upon 
the precise timing of exposure.  
The ethanol dose is known to be a critical determinant of developmental outcome, 
so it is unfortunate that relatively few investigators have attempted to calculate the intra-
embryonic ethanol concentration following developmental exposures. This shortcoming 
limits data interpretation, as it is very difficult to make meaningful comparisons between 
studies. I have conducted a series of experiments that investigate the dose-response 
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 relationship for developmental ethanol toxicity in medaka embryos. Using an optimized 
kinetic assay for ADH-mediated NADH accumulation, it was determined that medaka 
embryos take up approximately 60-70% of the waterborne ethanol concentration. This 
value is higher than previous estimates in zebrafish (~30%) and medaka embryos (20%) 
(Reimers et al. 2004; Wang et al. 2006a). Although I cannot offer a definitive explanation 
for this disparity, two methodological factors are of particular note; a longer exposure 
interval and saturating amounts of the cofactor NAD were used in the present ethanol 
assessments. It is possible that these modifications to the original protocol may have 
altered the extent of ethanol accumulation in the embryo or the reaction kinetics for 
NADH accumulation. Our findings, however, are compatible with an earlier study in 
goldfish which reported that ethanol rapidly achieves steady state in brain with tissue 
concentrations that are comparable to the waterborne ethanol concentration (Greizerstein 
and Smith 1973).  
The intra-embryonic ethanol dose attained in our experiments ranged from 12.0-
120 mM (0.07-0.7 %) after three consecutive days of ethanol exposure (0.1-1.0%). 
Although the highest ethanol dose used in these studies may be considered irrelevant to 
humans, it is comparable to that seen in other animal models of FAS. For example, rabbit 
embryos exposed to 154 mM ethanol from GD 9-11 were shown to develop cardiac and 
craniofacial abnormalities (Pitt and Carney 1999), whereas similar exposures in rodents 
(60 – 152 mM) from GD 6-16 produced craniofacial and neural tube defects (Becker et al. 
1996). In another, more extreme exposure paradigm, zebrafish embryos exposed to 2.4% 
ethanol (~ 425 mM) developed cyclopia which was accompanied by a loss of gene 
expression (sonic hedgehog; homebox nk2.2) in ventral forebrain and midbrain regions 
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 (Blader and Strähle 1998). Because the ethanol concentrations used in our experiments 
are within range of those used in previous studies, they are relevant for comparisons with 
other animal models of FAS.  
There have been relatively few studies of ethanol-induced teratogenesis in 
developing fish (Carvan et al. 2004; Reimers et al. 2004; Wang et al. 2006a), but the 
literature suggests that ethanol affects fish development in a manner which is similar to 
effects seen in mammals and birds (Abel and Dintcheff 1978; Baumann and Sander 1984; 
Cartwright and Smith 1995; Ghishan et al. 1982). A number of studies have documented 
ethanol-induced increases in stress proteins (Krone et al. 1997; Lele et al. 1997), spinal 
cord malformations (Laale 1971) and flexures of the body axis (Baumann and Sander 
1984) in zebrafish embryos. Our results indicate that medaka embryos are also highly 
sensitive to developmental ethanol exposure. Initial range finding experiments revealed 
that embryonic ethanol exposure at or above 2% is lethal during medaka development. In 
addition, exposures below this concentration produced dose-related deficits in medaka 
growth and development. Endpoints scored in these studies include hatching success and 
various measures of somatic growth. Of these, total body length and head width appeared 
to be most sensitive to developmental ethanol exposure. Embryos were relatively 
insensitive to ethanol-induced hatching delays, exhibiting treatment effects only at the 
highest dose. This high dose phenomenon may reflect ethanol-induced inhibition of the 
generation and/or migration of hatching gland cells. The fact that lower ethanol doses 
were ineffective suggests that the length of gestation may be “hard-wired”in the embryo, 
requiring intense disruptions that are overtly toxic in order to induce changes.  
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 The timing of developmental ethanol exposure is known to be a critical 
determinant of toxicity. Windows of heighted sensitivity to developmental ethanol 
toxicity have been identified in a number of species (Cartwright and Smith 1995; Coles et 
al. 1991; Tran et al. 2000; West et al. 1986). The pattern of effects described in Chapters 
3 and 4 indicate that temporal variations in ethanol toxicity also exist for medaka 
embryonic development. When exposed during early development (0-3 dpf), medaka 
embryos were found to be extremely sensitive to ethanol toxicity, exhibiting treatment 
related decreases in head width and total body length. A similar trend was observed with 
ethanol exposure late in development (6-9 dpf), indicating that this developmental 
window is also highly sensitive to ethanol exposure. It is intriguing to note however, that 
when ethanol was administered during the middle portion of development, embryos were 
less responsive to ethanol-induced decreases in total body length and brain volume. This 
may reflect the presence (or absence) of a specific cellular constituent at this particular 
time interval which effectively modulates toxicity. It could also indicate overlap between 
critical events that occur during early or late development. The lack of a precise temporal 
delineation of beginning or end, due to asynchronous development between embryos 
could skew results. In this case, responses to ethanol exposure would be expected to vary 
considerably during the interim between sensitive developmental events that occur early 
or late in gestation, which could theoretically mask treatment effects. 
No single mechanism can account for all of the adverse effects that have been 
observed in FAS, but animal models have identified several possibilities, many of which 
culminate as cell death via apoptosis or necrosis. There is also considerable evidence for 
ethanol-induced caspase-3 activation in the literature (Carloni et al. 2004; Climent et al. 
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 2002; Light et al. 2002; Mooney and Miller 2001; Ramachandran et al. 2001). Though 
often viewed in terms of apoptotic potential, the relationship between caspase-3 and cell 
death is not absolute. Modulations in caspase activity may also induce subtle changes in 
the orderly sequence of events that orchestrate normal embryonic development. Since the 
total cell number of an embryo is determined via summation of additive (cell 
proliferation, neuronal migration and neurite outgrowth) and subtractive (pruning and 
neuronal cell death) processes and ethanol affects all of these developmental events 
(Bhave and Hoffman 1997; Borges and Lewis 1983; Climent et al. 2002; Luo and Miller 
1997; Pantazis et al. 1993; Vaudry et al. 2002; Zhang et al. 1998a), it is unlikely that a 
change in caspase activation would be the sole determinant of ethanol-induced decreases 
in cell density. 
Although developmental ethanol exposure has been shown to decrease neuronal 
survival, recent evidence suggests that all neurons exhibiting the common cell death 
markers (e.g., TUNEL, caspase) do not die (Cheng and Zochodne 2003; Gordon et al. 
2002; Ishida et al. 2004; Oomman et al. 2004). In fact, stereological estimates indicate 
that the loss of cortical neurons following developmental ethanol exposure is less than 
33% (Mooney et al. 1996; Mooney and Napper 2005). Perhaps the switch for caspase 
activation is incremental rather than ON/OFF. In some instances when appropriate 
neuronal cues are not present, the damage which triggers caspase activation may actually 
represent a “sublethal” insult that causes developing circuits to enter a “waiting stage” in 
order to allow time for the necessary input (or more favorable conditions) to become 
available. 
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 In the present study, all animals exposed to 1% ethanol during development 
exhibited substantial, treatment-related changes in caspase-3/7 activity, however the 
nature of the observed changes varied with the timing of exposure. Early ethanol 
exposure increased, whereas mid to late gestational exposure decreased caspase-3/7 
activity. A similar trend has been observed in chick embryos. In this model, the extent of 
ethanol-induced cell death was increased relative to controls with early ethanol exposures 
(gastrulation or neurulation), but not with those that occurred later in development (e.g., 
16 somite stage) (Cartwright and Smith 1995).  
Though it is generally well-accepted that increased caspase-3/7 activation can be 
equated with increased apoptosis, it is becoming increasingly clear that this long held 
notion may be too simplistic, as caspase-3/7 is known to possess non-apoptotic functions 
as well. For example, caspase-3/7 has been shown to play a pivotal role in cellular 
differentiation [(Ishizaki et al. 1998); for recent reviews see Abraham and Shaham 2004; 
Launay et al. 2005; Sehra and Dent 2006] and neuronal pruning (Kozlowski et al. 1997; 
Miller 1987). Since these developmental processes are highly integrated, it is appealing to 
speculate that the observed spatiotemporal variations in ethanol-induced caspase 
activation may, to some degree, reflect normal fluctuations in the extent of programmed 
cell death that occurs naturally during different stages of development. It is important to 
note however, that the present results reflect whole embryo caspase activity and as such, 
are not exclusively related to nervous system development.  
The relationship between caspase activation and programmed cell death can be 
ambiguous. Our results are consistent with a recent study in rats that reported ethanol-
induced decreases in caspase-3 activity in the pancreas (Wang et al. 2006b). Though 
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 somewhat counterintuitive, the idea that ethanol might decrease caspase activity is not 
inconceivable. In some situations where caspases are normally activated, their inhibition 
simply delays, rather than prevents cell death (D'Mello et al. 2000; Keramaris et al. 2000; 
Selznick et al. 2000; Stefanis et al. 1999). Hence changes in caspase activation may not 
directly correlate with spatiotemporal patterns of cell death.  
Developmental ethanol exposure is known to decrease cortical expression of pro-
survival proteins (Mooney and Miller 2001), whereas transgenic over-expression of Bcl-2 
has been shown to protect cerebellar Purkinje neurons from ethanol-induced cell death 
(Heaton et al. 1999). In addition, net decreases in the Bcl-2/Bax ratio observed in rat 
brain were shown to coincide with periods of enhanced ethanol-induced cell death in 
cortical proliferative zones (Mooney and Miller 2001), suggesting a critical role for these 
proteins in apoptotic signaling. A lack of ethanol-related changes in Bcl-2 or Bax 
expression was observed in the ventrolateral nucleus of the thalamus, a structure that 
appears relatively insensitive to ethanol-induced cell death (Livy et al. 2001). An ethanol 
effect on cell death factors related to p53 signaling has also been surmised. The temporal 
pattern associated with ethanol-induced changes in p53 expression resembles that seen 
with ethanol-induced changes in Bcl-2 expression; ethanol exposure during gestation 
increased prenatal p53 expression in rat cortex (Kuhn and Miller 1998). Chronic prenatal 
ethanol exposure was also shown to increase p53 expression in rat cerebellum during the 
early postnatal period (de la Monte and Wands 2002). Implicit in these findings is the 
notion that the functional reserve for CNS recovery processes may vary significantly 
across brain regions and stages of development. That is, observed variations in the 
  91
 inherent sensitivity to ethanol-induced cell death may reflect region- and time-specific 
gradients in the relative abundance of pro-survival and/or apoptotic effector molecules. 
Morphometric studies in rodents treated with ethanol during development have 
shown that the size of the brain may be as much as 12-30% smaller in treated animals 
relative to controls (Pentney and Miller 1992). Variability in the sensitivity to this 
response may reflect differences in the method of ethanol administration and/or the 
timing of exposure (Lancaster et al. 1982; Miller and Potempa 1990; Pierce and West 
1987; Randall et al. 1977; Samson and Diaz 1981; Stoltenburg-Didinger and Spohr 1983). 
I have addressed temporal variations in ethanol toxicity, using a consistent intra-
embryonic ethanol dose for all comparisons across early, middle or late development. 
Since there is a strong correlation between developmental ethanol-exposure and growth 
retardation, this growth inhibitory phenomenon was used to determine which interval of 
medaka development is most susceptible to ethanol toxicity. Results obtained from initial 
morphometric studies implicate the first and last developmental windows as particularly 
sensitive periods for ethanol-induced growth inhibition. However subsequent assessments 
of ethanol-induced changes in brain volume clearly indicate that the first developmental 
window is most sensitive to ethanol-induced inhibition of brain growth. Since Adh8 
expression (which is considered to be functionally analogous to human ADH1) is not 
increased until ~72 hpf (Dasmahapatra et al. 2005) this may partially explain the 
increased growth inhibition observed in embryos treated during the first exposure 
window. The temporal relationship between changes in embryonic capacity for ethanol 
metabolism and heightened sensitivity to developmental ethanol exposure is unclear. 
Once absorbed, ethanol distributes rapidly within the total body water and readily diffuses 
  92
 across cell membranes (reviewed in Rogers and Daston 1997), where it is oxidized to 
acetaldehyde by alcohol dehydrogenase, CYP2E1 and catalase. Of these, ADH1 is 
responsible for the bulk of ethanol metabolism in the liver (Boleda et al. 1989).  
Although direct (ethanol) and indirect (acetaldehyde) mechanisms have been 
proposed for the negative effects of developmental ethanol exposure, a recent zebrafish 
study showed that inhibition of ethanol metabolism dramatically increased the incidence 
and severity of ethanol toxicity in developing zebrafish embryos (Reimers et al. 2004). A 
number of other studies support the contention that metabolic conversion of ethanol to 
acetaldehyde is not necessary for inducing teratogenic effects in vivo. For example, dose-
dependent increases in lethality and malformations were enhanced in rats and mice that 
were co-exposed to ethanol and 4-methyl pyrazole, an inhibitor of alcohol dehydrogenase 
(Blakley and Scott 1984; Chen et al. 1995). This notion is further strengthened by the fact 
that ethanol sensitivity was shown to be inversely related to ADH activity in the fruit fly 
(Drosophila melanogaster). In these studies, flies with the lowest ADH activity had twice 
as many malformations as those that possessed high ADH activity (Ranganathan et al. 
1987). These findings are consistent with morphometric data presented in this thesis 
which indicate that medaka embryos are most sensitive to ethanol-induced growth 
inhibition during the first 72 hours of development, when Adh8 expression is minimal. 
Another possible explanation relates to temporal variations in the cellular 
environment which may impact adaptive responses to ethanol toxicity. For example, 
neurotrophin expression and neuronal dependence on trophic support vary in a region- 
and time-dependent manner during development. Purkinje cells switch from BDNF to 
NT-3 support between P4 and P6 (Davies 1997), which is a period of heightened 
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 sensitivity to ethanol exposure (Light et al. 2002). Developmental ethanol exposure may 
interrupt neurotrophic signaling in a number of ways, depending upon the neuronal 
population and the time of exposure. Pre- (Miller and Potempa 1990) and postnatal 
(Mooney et al. 1996) ethanol exposure have been shown to produce comparable decreases 
in rat cortical neurons. Interestingly, treatment-related decreases in neuronal density were 
coincident with changes in gene expression profiles that influence neuronal death. For 
example, Bcl-2 and caspase-3 expression normally increase in the neocortex during the 
first two weeks of postnatal development, but ethanol exposure effectively delayed this 
up-regulation (Mooney and Miller 2001). We observed similar treatment-related delays in 
caspase-3 activation following ethanol exposure in medaka embryos. 
Although ethanol-induced growth inhibition is a salient feature of developmental 
ethanol toxicity, a more comprehensive strategy may prove useful for identifying critical 
windows for developmental ethanol toxicity. It is possible that periods of heightened 
sensitivity are not adequately defined by chronological age. A more accurate 
representation of these developmental intervals may require incorporation of elements 
associated with the immediate cellular environment. The mere fact that there are so many 
different manifestations of developmental ethanol toxicity suggests that ethanol-induced 
physiological responses may be tempered by the “tone” of the microenvironment in an 
affected region at the time of exposure. This phenomenon has been documented in the 
ethanol literature, where, in addition to its ability to destroy cerebellar (Li et al. 2002) 
and cortical (Jacobs and Miller 2001) neurons, developmental ethanol exposure has been 
shown to delay proliferation of cerebellar (Li et al. 2002) and cortical (Miller et al. 2003) 
progenitor cells and to decrease the rate of neuronal migration (Miller 1993). These 
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 compensatory responses are not necessarily maladaptive. They most likely represent an 
attempt to re-establish homeostasis and in so doing, serve to promote survival. Embryonic 
development is a dynamic process which is highly responsive to a myriad of intracellular 
and environmental cues. As such, the delineation of critical periods for enhanced 
sensitivity may not be one dimensional.  
Future Directions 
A growing body of evidence indicates that genetic background can modulate the 
addictive and neurobehavioral properties of ethanol. Studies in rodents, birds, and 
humans indicate that sensitivity and resistance to ethanol toxicity is influenced by the 
genotype of the organism (Bruyere and Stith 1993; Bupp Becker and Shibley; Fatayerji et 
al. 1996; Loucks and Carvan 2004; Pecsenye et al. 2004). Genetic polymorphisms in 
ethanol metabolizing enzymes (Chernoff 1980; Itoga et al. 1999; Whitfield et al. 1997), 
neurotransmitter systems (Gelernter et al. 1997; Parsian et al. 1996) and quantitative trait 
loci (Crabbe et al. 1999) have been identified. Other modulators of developmental ethanol 
toxicity may be independent of maternal metabolism, as demonstrated in crosses between 
susceptible (Long Sleep) C57BL/6J and resistant (Short-Sleep) C57BL/6J mice. In these 
studies, Long Sleep, but not Short Sleep mice experienced growth (Goodlett et al. 1989) 
and learning (Gilliam et al.) deficits. The medaka early life stage assay is a relatively 
simple developmental model that has the potential to advance our understanding of 
differential susceptibility to ethanol-induced teratogenesis. Genetically distinct medaka 
strains could be used to address this possibility, by comparing gene expression profiles 
for ethanol exposed and control embryos in order to identify candidate genes that may 
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 contribute to differential sensitivity. Utilizing cDNA microarray techniques, researchers 
can test numerous end points simultaneously. Those strains which exhibit heightened 
sensitivity could later be subjected to learning and memory (or drug challenge) studies to 
determine the longterm consequences of developmental ethanol exposure. The ability to 
correlate changes in gene expression with changes in behavior and cognitive function will 
facilitate rapid progress in this research area.  
An efficient and cost-effective means to ascertain risk is perhaps the most widely 
sought commodity in hazard management. Research presented in this thesis demonstrates 
the sensitivity and reliability of the medaka early life stage assay as an alternative 
approach for assessments of ethanol and possibly other, known or suspected 
developmental toxicants.  
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